{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T03:34:54Z","timestamp":1792294494038,"version":"4.4.0"},"reference-count":570,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Disease-a-Month"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.disamonth.2025.101853","type":"journal-article","created":{"date-parts":[[2025,1,13]],"date-time":"2025-01-13T22:04:22Z","timestamp":1736805862000},"page":"101853","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Opioid use and abuse in adolescents and young adults; dealing with science, laws and ethics: Charming the COBRAS"],"prefix":"10.1016","volume":"71","author":[{"given":"Donald E.","family":"Greydanus","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahsan","family":"Nazeer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dilip R.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.disamonth.2025.101853_bib0001","article-title":"Homo sapiens sapiens","author":"Rafferty","year":"2023","journal-title":"Encyclop Britannica"},{"issue":"4","key":"10.1016\/j.disamonth.2025.101853_bib0002","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1037\/h0054346","article-title":"A theory of human motivation","volume":"50","author":"Maslow","year":"1943","journal-title":"Psychol Rev"},{"issue":"2","key":"10.1016\/j.disamonth.2025.101853_bib0003","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1037\/1089-2680.9.2.111","article-title":"Pursuing happiness: the architecture of sustainable change","volume":"9","author":"Lyubomirsky","year":"2005","journal-title":"Rev Gen Psychol"},{"key":"10.1016\/j.disamonth.2025.101853_bib0004","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1146\/annurev.psych.52.1.141","article-title":"On happiness and human potentials: a review of research on hedonic and eudaimonic well-being","volume":"52","author":"Ryan","year":"2001","journal-title":"Ann Rev Psychol (Palo Alto)"},{"key":"10.1016\/j.disamonth.2025.101853_bib0005","series-title":"Evolution: The First Four Billion Years","first-page":"265","article-title":"Human Evolution","author":"McHenry","year":"2009"},{"key":"10.1016\/j.disamonth.2025.101853_bib0006","series-title":"The First Writing: Script Invention As History and Process","author":"Houston","year":"2004"},{"key":"10.1016\/j.disamonth.2025.101853_bib0007","series-title":"Substance Abuse in Adolescents and Young adults: A manual For Pediatric and Primary Care Clinicians","first-page":"389","author":"Greydanus","year":"2019"},{"issue":"3","key":"10.1016\/j.disamonth.2025.101853_bib0008","first-page":"107","article-title":"Substance abuse: a growing problem for adolescents","volume":"76","author":"Greydanus","year":"1986","journal-title":"Iowa Med"},{"issue":"4","key":"10.1016\/j.disamonth.2025.101853_bib0009","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1007\/BF02727170","article-title":"Substance abuse: a pediatric concern","volume":"66","author":"Patel","year":"1999","journal-title":"Indian J Pediatr"},{"issue":"7","key":"10.1016\/j.disamonth.2025.101853_bib0010","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.disamonth.2005.10.002","article-title":"The adolescent and substance abuse: current concepts","volume":"51","author":"Greydanus","year":"2005","journal-title":"Dis Mon"},{"issue":"3","key":"10.1016\/j.disamonth.2025.101853_bib0011","first-page":"78","article-title":"The adolescent and substance abuse: current concepts","volume":"35","author":"Greydanus","year":"2005","journal-title":"Curr Probl Pediatr Adolesc Health Care"},{"issue":"5","key":"10.1016\/j.disamonth.2025.101853_bib0012","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/S0031-3955(03)00079-8","article-title":"Substance abuse in adolescents: a complex conundrum for the clinician","volume":"50","author":"Greydanus","year":"2003","journal-title":"Pediatr Clin North Am"},{"issue":"9","key":"10.1016\/j.disamonth.2025.101853_bib0013","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.medcli.2023.11.016","article-title":"Substance use disorder: epidemiology, medical consequences and treatment","volume":"162","author":"Fuster","year":"2024","journal-title":"Med Clin (Barc)"},{"key":"10.1016\/j.disamonth.2025.101853_bib0014","series-title":"Paleobotany and the Evolution of Plants","first-page":"521","author":"Stewart","year":"1993"},{"key":"10.1016\/j.disamonth.2025.101853_bib0015","article-title":"The Editors of Encyclopaedia. \"Genesis\"","year":"2024","journal-title":"Encyclop Britannica"},{"key":"10.1016\/j.disamonth.2025.101853_bib0016","series-title":"Medical History, Some Perspectives","first-page":"434","author":"Greydanus","year":"2018"},{"issue":"4","key":"10.1016\/j.disamonth.2025.101853_bib0017","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.disamonth.2015.01.004","article-title":"Cannabis: the never-ending, nefarious nepenthe of the 21st century: what should the clinician know?","volume":"61","author":"Greydanus","year":"2015","journal-title":"Dis Mon"},{"key":"10.1016\/j.disamonth.2025.101853_bib0018","unstructured":"Rawlinson G. The Histories. Herodotus of halicarnassus. 430 BC. Translated in 1858. http:\/\/classics.mit.edu\/Herodotus\/history.html."},{"issue":"10","key":"10.1016\/j.disamonth.2025.101853_bib0019","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/j.phymed.2016.06.016","article-title":"Back to the roots: a quantitative survey of herbal drugs in Dioscorides' De Materia Medica (ex Matthioli, 1568)","volume":"23","author":"Staub","year":"2016","journal-title":"Phytomedicine"},{"key":"10.1016\/j.disamonth.2025.101853_bib0020","series-title":"A Brief History of Drugs: From the Stone Age to the Stoned Age","first-page":"176","author":"Escohotada","year":"1999"},{"issue":"2","key":"10.1016\/j.disamonth.2025.101853_bib0021","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1080\/00952990.2024.2308098","article-title":"Medicinal cannabis use among young adults during California's transition from legalized medical use to adult-use: a longitudinal analysis","volume":"50","author":"Ataiants","year":"2024","journal-title":"Am J Drug Alcohol Abuse"},{"issue":"7","key":"10.1016\/j.disamonth.2025.101853_bib0022","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1111\/add.16456","article-title":"The risk relationships between alcohol consumption, alcohol use disorder and alcohol use disorder mortality: a systematic review and meta-analysis","volume":"119","author":"Carr","year":"2024","journal-title":"Addiction"},{"issue":"6","key":"10.1016\/j.disamonth.2025.101853_bib0023","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1111\/add.16446","article-title":"The association between alcohol consumption and all-cause mortality: an umbrella review of systematic reviews using lifetime abstainers or low-volume drinkers as a reference group","volume":"119","author":"Sarich","year":"2024","journal-title":"Addiction"},{"issue":"5","key":"10.1016\/j.disamonth.2025.101853_bib0024","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1007\/s11121-024-01679-6","article-title":"Young adult alcohol and cannabis impaired driving after the opening of cannabis retail stores in Washington State","volume":"25","author":"Hultgren","year":"2024","journal-title":"Prev Sci"},{"key":"10.1016\/j.disamonth.2025.101853_bib0025","unstructured":"United States. Surgeon General's Advisory Committee on Smoking and Health United States. Public Health Service. Office of the Surgeon General Luther Terry Surgeon General Report, 386 pages, 1964."},{"issue":"Suppl 1","key":"10.1016\/j.disamonth.2025.101853_bib0026","first-page":"253","article-title":"Health needs of the nation. 1961","volume":"121","author":"Terry","year":"2006","journal-title":"Public Health Rep"},{"key":"10.1016\/j.disamonth.2025.101853_bib0027","series-title":"A report of the Surgeon General","year":"2012"},{"issue":"3","key":"10.1016\/j.disamonth.2025.101853_bib0028","first-page":"158","article-title":"Addiction to tobacco smoking and vaping","volume":"75","author":"Hern\u00e1ndez-P\u00e9rez","year":"2023","journal-title":"Rev Invest Clin"},{"key":"10.1016\/j.disamonth.2025.101853_bib0029","series-title":"Forces of Habit","first-page":"298","article-title":"Courtwright","author":"David","year":"2001"},{"key":"10.1016\/j.disamonth.2025.101853_bib0030","series-title":"The Oxford Guide to People and Places of the Bible","first-page":"62","author":"Metzger","year":"2004"},{"issue":"2","key":"10.1016\/j.disamonth.2025.101853_bib0031","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/ardp.18601530202","article-title":"[Ueber eine neue organische Base in den Cocabl\u00e4ttern","volume":"153","author":"Niemann","year":"1860","journal-title":"Arch Pharm (Weinheim)"},{"key":"10.1016\/j.disamonth.2025.101853_bib0032","first-page":"289","article-title":"\u00dcber Coca. Centralblatt f\u00fcr die ges","volume":"2","author":"Freud","year":"1884","journal-title":"Therapie"},{"key":"10.1016\/j.disamonth.2025.101853_bib0033","first-page":"1565","article-title":"Cocaine addiction 100 years ago. A. Erlenmeyer: uber cocainsucht. [Deutsch]","volume":"75","author":"Koelbing","year":"1986","journal-title":"Medizinal Zeitung"},{"issue":"10","key":"10.1016\/j.disamonth.2025.101853_bib0034","doi-asserted-by":"crossref","first-page":"eaax1532","DOI":"10.1126\/sciadv.aax1532","article-title":"The treatment of cocaine use disorder","volume":"5","author":"Kampman","year":"2019","journal-title":"Sci Adv."},{"issue":"4","key":"10.1016\/j.disamonth.2025.101853_bib0035","doi-asserted-by":"crossref","first-page":"278","DOI":"10.3390\/toxins14040278","article-title":"On Behalf Of The Oemonom Researchers. Cocaine: an updated overview on chemistry, detection, biokinetics, and pharmacotoxicological sspects including abuse pattern","volume":"14","author":"Roque Bravo","year":"2022","journal-title":"Toxins (Basel)"},{"key":"10.1016\/j.disamonth.2025.101853_bib0036","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/S0031-3955(03)00081-6","article-title":"Attention-deficit\/hyperactivity disorder in children and adolescents: interventions for a complex costly clinical conundrum","volume":"50","author":"Greydanus","year":"2003","journal-title":"Pediatr Clin N Am"},{"issue":"2","key":"10.1016\/j.disamonth.2025.101853_bib0037","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1080\/02791072.2000.10400221","article-title":"History of the methamphetamine problem","volume":"32","author":"Anglin","year":"2000","journal-title":"J Psychoactive Drugs"},{"key":"10.1016\/j.disamonth.2025.101853_bib0038","series-title":"StatPearls [Internet]","article-title":"Methamphetamine","author":"Yasaei","year":"2023"},{"key":"10.1016\/j.disamonth.2025.101853_bib0039","series-title":"StatPearls [Internet]","article-title":"Methamphetamine toxicity","author":"Richards","year":"2023"},{"key":"10.1016\/j.disamonth.2025.101853_bib0040","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2023.1229439","article-title":"Oxycodone, an opioid like the others?","volume":"14","author":"Marie","year":"2023","journal-title":"Front Psychiatry"},{"issue":"1","key":"10.1016\/j.disamonth.2025.101853_bib0041","doi-asserted-by":"crossref","first-page":"22","DOI":"10.2307\/1190429","article-title":"The history of development of narcotics","volume":"22","author":"Eddy","year":"1957","journal-title":"Law & Contemp Prob"},{"key":"10.1016\/j.disamonth.2025.101853_bib0042","series-title":"Der Papyrus Ebers. Die gr\u00f6sste Buchrolle zur Heilkunde Alt\u00e4gyptens (Schriften Aus Der Universit\u00e4tsbibliothek 7)","author":"Scholl","year":"2002"},{"issue":"1","key":"10.1016\/j.disamonth.2025.101853_bib0043","doi-asserted-by":"crossref","first-page":"iii","DOI":"10.1016\/j.pcl.2010.11.005","article-title":"Preface: pediatric and adolescent psychopharmacology","volume":"58","author":"Greydanus","year":"2011","journal-title":"Pediatric Clin North Am"},{"key":"10.1016\/j.disamonth.2025.101853_bib0044","series-title":"Pediatric Practice: Sports Medicine","first-page":"63","article-title":"Performance-enhancing drugs and supplements","author":"Greydanus","year":"2009"},{"key":"10.1016\/j.disamonth.2025.101853_bib0045","first-page":"492","article-title":"Friedrich Wilhelm Adam Sert\u00fcrner\u2013dem Entdecker des Morphins zum 150. Todestag [Friedrich Wilhelm Adam Sert\u00fcrner\u2212the discoverer of morphine]","volume":"26","author":"Goerig","year":"1991"},{"issue":"10","key":"10.1016\/j.disamonth.2025.101853_bib0046","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1021\/acschemneuro.8b00150","article-title":"DARK classics in chemical neuroscience: morphine","volume":"9","author":"Devereaux","year":"2018","journal-title":"ACS Chem Neurosci"},{"key":"10.1016\/j.disamonth.2025.101853_bib0047","series-title":"The Opium War Through Chinese eyes","author":"Waley","year":"1958"},{"issue":"2","key":"10.1016\/j.disamonth.2025.101853_bib0048","first-page":"233","article-title":"A heroin t\u00f6rt\u00e9nete [The history of heroin]","volume":"71","author":"Hosztafi","year":"2001","journal-title":"Acta Pharm Hung"},{"issue":"4","key":"10.1016\/j.disamonth.2025.101853_bib0049","doi-asserted-by":"crossref","first-page":"437","DOI":"10.3390\/ph17040437","article-title":"The 125th anniversary of aspirin-The story continues","volume":"17","author":"Werz","year":"2024","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1016\/j.disamonth.2025.101853_bib0050","doi-asserted-by":"crossref","DOI":"10.1177\/20451253221139616","article-title":"Synthetic opioids: a review and clinical update","volume":"12","author":"Shafi","year":"2022","journal-title":"Ther Adv Psychopharmacol"},{"key":"10.1016\/j.disamonth.2025.101853_bib0051","series-title":"Vignettes On Surgery, History and the Humanities","first-page":"200","author":"Toledo-Pereyra","year":"2005"},{"issue":"1","key":"10.1016\/j.disamonth.2025.101853_bib0052","doi-asserted-by":"crossref","first-page":"18","DOI":"10.2105\/AJPH.75.1.18","article-title":"Industry invites regulation: the passage of the Pure Food and Drug Act of 1906","volume":"75","author":"Barkan","year":"1985","journal-title":"Am J Public Health"},{"issue":"6","key":"10.1016\/j.disamonth.2025.101853_bib0053","doi-asserted-by":"crossref","first-page":"518","DOI":"10.2105\/AJPH.5.6.518","article-title":"The Harrison Anti-Narcotic Act","volume":"5","author":"Terry","year":"1915","journal-title":"Am J Public Health (N Y)"},{"key":"10.1016\/j.disamonth.2025.101853_bib0054","series-title":"Substance Abuse in Adolescents and Young Adults: A Manual For Pediatric and Primary Care Clinicians","first-page":"51","article-title":"The current US opioid epidemic: historical perspective and review of proposed solutions","author":"Kaplan","year":"2019"},{"issue":"2","key":"10.1016\/j.disamonth.2025.101853_bib0055","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1056\/NEJM198001103020221","article-title":"Addiction rare in patients treated with narcotics","volume":"302","author":"Porter","year":"1980","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.disamonth.2025.101853_bib0056","doi-asserted-by":"crossref","first-page":"58","DOI":"10.4103\/0974-2700.179454","article-title":"Pressured to prescribe\" The impact of economic and regulatory factors on South-Eastern ED physicians when managing the drug seeking patient","volume":"9","author":"Kelly","year":"2016","journal-title":"J Emerg Trauma Shock"},{"issue":"5","key":"10.1016\/j.disamonth.2025.101853_bib0057","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.jamcollsurg.2020.07.508","article-title":"Pain as the fifth vital sign","volume":"231","author":"Rogers","year":"2020","journal-title":"J Am Coll Surg"},{"issue":"9","key":"10.1016\/j.disamonth.2025.101853_bib0058","first-page":"e44716","article-title":"Looking back, moving forward in pain medicine","volume":"15","author":"Paladini","year":"2023","journal-title":"Cureus"},{"key":"10.1016\/j.disamonth.2025.101853_bib0059","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.jflm.2018.12.005","article-title":"Metabolism and metabolomics of opiates: a long way of forensic implications to unravel","volume":"61","author":"Dinis-Oliveira","year":"2019","journal-title":"J Forensic Leg Med"},{"issue":"1","key":"10.1016\/j.disamonth.2025.101853_bib0060","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1080\/10550887.2021.1916420","article-title":"Adolescents and opioid-related outcomes amidst the COVID-19 pandemic","volume":"40","author":"Romero","year":"2022","journal-title":"J Addict Dis"},{"issue":"14","key":"10.1016\/j.disamonth.2025.101853_bib0061","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1001\/jama.2022.2847","article-title":"Trends in drug overdose deaths among US adolescents, January 2010 to June 2021","volume":"327","author":"Friedman","year":"2022","journal-title":"JAMA"},{"key":"10.1016\/j.disamonth.2025.101853_bib0062","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2021.108019","article-title":"Treatment of overdose in the synthetic opioid era","volume":"233","author":"Skolnick","year":"2022","journal-title":"Pharmacol Ther"},{"issue":"4","key":"10.1016\/j.disamonth.2025.101853_bib0063","first-page":"280","article-title":"Fentanyl drives startling increases in adolescent overdose deaths","volume":"329","author":"Kuehn","year":"2023","journal-title":"JAMA"},{"issue":"S2","key":"10.1016\/j.disamonth.2025.101853_bib0064","doi-asserted-by":"crossref","first-page":"S93","DOI":"10.2105\/AJPH.2022.306816","article-title":"The global opioid overdose crisis","volume":"112","author":"de Camargo","year":"2022","journal-title":"Am J Public Health"},{"issue":"2","key":"10.1016\/j.disamonth.2025.101853_bib0065","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1007\/s11419-022-00624-y","article-title":"Non-fentanyl-derived synthetic opioids emerging during recent years","volume":"40","author":"Hasegawa","year":"2022","journal-title":"Forensic Toxicol"},{"key":"10.1016\/j.disamonth.2025.101853_bib0066","series-title":"Substance Abuse in Adolescents and Young Adults: A Manual For Pediatric and Primary Care Clinicians","first-page":"3","article-title":"Muhammad Waqar Azeem. Neurobiology of substance use disorders","author":"Nazeer","year":"2019"},{"key":"10.1016\/j.disamonth.2025.101853_bib0067","series-title":"Behavioral Pediatrics. Mental Health and Management","first-page":"117","article-title":"Neurobiology of substance use disorders","author":"Hashemi","year":"2022"},{"key":"10.1016\/j.disamonth.2025.101853_bib0068","series-title":"Diagnostic and Statistical Manual of Mental Disorders","author":"Association","year":"2013"},{"key":"10.1016\/j.disamonth.2025.101853_bib0069","doi-asserted-by":"crossref","DOI":"10.1177\/17448069241260348","article-title":"Morphine acts in vitro to directly prime nociceptors","volume":"20","author":"Khomula","year":"2024","journal-title":"Mol Pain"},{"issue":"1","key":"10.1016\/j.disamonth.2025.101853_bib0070","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1523\/JNEUROSCI.2160-20.2020","article-title":"Opioid-induced hyperalgesic priming in single nociceptors","volume":"41","author":"Khomula","year":"2021","journal-title":"J Neurosci"},{"key":"10.1016\/j.disamonth.2025.101853_bib0071","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/978-3-662-46450-2_2","article-title":"The pharmacology of nociceptor priming","volume":"227","author":"Kandasamy","year":"2015","journal-title":"Handb Exp Pharmacol"},{"issue":"9","key":"10.1016\/j.disamonth.2025.101853_bib0072","doi-asserted-by":"crossref","first-page":"2226","DOI":"10.1523\/JNEUROSCI.3476-17.2018","article-title":"Fentanyl induces rapid onset hyperalgesic priming: type I at peripheral and Type II at central nociceptor terminals","volume":"38","author":"Araldi","year":"2018","journal-title":"J Neurosci"},{"issue":"8","key":"10.1016\/j.disamonth.2025.101853_bib0073","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/j.biopsych.2017.10.030","article-title":"The multifaceted role of the ventromedial prefrontal cortex in emotion, decision making, social cognition, and psychopathology","volume":"83","author":"Hiser","year":"2018","journal-title":"Biol Psychiatry"},{"issue":"3","key":"10.1016\/j.disamonth.2025.101853_bib0074","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1093\/cercor\/10.3.206","article-title":"The organization of networks within the orbital and medial prefrontal cortex of rats, monkeys and humans","volume":"10","author":"Ong\u00fcr","year":"2000","journal-title":"Cereb Cortex"},{"issue":"7","key":"10.1016\/j.disamonth.2025.101853_bib0075","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1097\/FBP.0000000000000424","article-title":"Dopamine and reward: a view from the prefrontal cortex","volume":"29","author":"Chau","year":"2018","journal-title":"Behav Pharmacol"},{"key":"10.1016\/j.disamonth.2025.101853_bib0076","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0079-6123(00)26015-9","article-title":"Involvement of basal ganglia and orbitofrontal cortex in goal-directed behavior","volume":"126","author":"Hollerman","year":"2000","journal-title":"Prog Brain Res"},{"issue":"2","key":"10.1016\/j.disamonth.2025.101853_bib0077","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1080\/17588928.2024.2354706","article-title":"The hippocampus and implicit memory","volume":"15","author":"Slotnick","year":"2024","journal-title":"Cogn Neurosci"},{"issue":"11","key":"10.1016\/j.disamonth.2025.101853_bib0078","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuron.2024.02.021","article-title":"Interaction of acetylcholine and oxytocin neuromodulation in the hippocampus","volume":"112","author":"Zhang","year":"2024","journal-title":"Neuron"},{"issue":"4","key":"10.1016\/j.disamonth.2025.101853_bib0079","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.3390\/ijms25041991","article-title":"Vulnerability of the hippocampus to insults: links to blood-brain barrier dysfunction","volume":"25","author":"Davidson","year":"2024","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.disamonth.2025.101853_bib0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropsychologia.2023.108777","article-title":"The role of recollection, familiarity, and the hippocampus in episodic and working memory","volume":"193","author":"Yonelinas","year":"2024","journal-title":"Neuropsychologia"},{"issue":"5","key":"10.1016\/j.disamonth.2025.101853_bib0081","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuron.2023.11.023","article-title":"D1 and D2 medium spiny neurons in the nucleus accumbens core have distinct and valence-independent roles in learning","volume":"112","author":"Zachry","year":"2024","journal-title":"Neuron"},{"issue":"3","key":"10.1016\/j.disamonth.2025.101853_bib0082","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuron.2023.10.020","article-title":"A stress-sensitive frontostriatal circuit supporting effortful reward-seeking behavior","volume":"112","author":"Fetcho","year":"2024","journal-title":"Neuron"},{"issue":"8015","key":"10.1016\/j.disamonth.2025.101853_bib0083","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/s41586-024-07440-x","article-title":"Distinct \u00b5-opioid ensembles trigger positive and negative fentanyl reinforcement","volume":"630","author":"Chaudun","year":"2024","journal-title":"Nature"},{"issue":"6693","key":"10.1016\/j.disamonth.2025.101853_bib0084","doi-asserted-by":"crossref","first-page":"eadk6742","DOI":"10.1126\/science.adk6742","article-title":"Drugs of abuse hijack a mesolimbic pathway that processes homeostatic need","volume":"384","author":"Tan","year":"2024","journal-title":"Science"},{"key":"10.1016\/j.disamonth.2025.101853_bib0085","doi-asserted-by":"crossref","DOI":"10.1038\/s41380-024-02623-4","article-title":"The ion channel TRPA1 is a modulator of the cocaine reward circuit in the nucleus accumbens","author":"Kim","year":"2024","journal-title":"Mol Psychiatry"},{"issue":"2","key":"10.1016\/j.disamonth.2025.101853_bib0086","first-page":"111","article-title":"From Roentgen to magnetic resonance imaging: the history of medical imaging","volume":"75","author":"Scatliff","year":"2014","journal-title":"N C Med J"},{"issue":"5394","key":"10.1016\/j.disamonth.2025.101853_bib0087","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1038\/242190a0","article-title":"Image formation by induced local interactions: examples of employing nuclear magnetic resonance","volume":"242","author":"Lauterbur","year":"1973","journal-title":"Nature"},{"issue":"244","key":"10.1016\/j.disamonth.2025.101853_bib0088","first-page":"3","article-title":"Image formation by induced local interactions. Examples employing nuclear magnetic resonance. 1973","author":"Lauterbur","year":"1989","journal-title":"Clin Orthop Relat Res"},{"issue":"4533","key":"10.1016\/j.disamonth.2025.101853_bib0089","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1126\/science.215.4533.619","article-title":"Positron tomography and nuclear magnetic resonance imaging","volume":"215","author":"Brownell","year":"1982","journal-title":"Science"},{"issue":"2 Suppl","key":"10.1016\/j.disamonth.2025.101853_bib0090","doi-asserted-by":"crossref","first-page":"S181","DOI":"10.1148\/radiol.14140706","article-title":"The history of MR imaging as seen through the pages of radiology","volume":"273","author":"Edelman","year":"2014","journal-title":"Radiology"},{"issue":"2","key":"10.1016\/j.disamonth.2025.101853_bib0091","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.jmr.2011.08.023","article-title":"Recollections about our 1996 JMR paper on diffusion anisotropy","volume":"213","author":"Basser","year":"2011","journal-title":"J Magn Reson"},{"issue":"2","key":"10.1016\/j.disamonth.2025.101853_bib0092","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1148\/radiology.161.2.3763909","article-title":"MR imaging of intravoxel incoherent motions: application to diffusion and perfusion in neurologic disorders","volume":"161","author":"Le Bihan","year":"1986","journal-title":"Radiology"},{"key":"10.1016\/j.disamonth.2025.101853_bib0093","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuroimage.2023.120003","article-title":"A novel framework for in-vivo diffusion tensor distribution MRI of the human brain","volume":"271","author":"Magdoom","year":"2023","journal-title":"Neuroimage"},{"issue":"8","key":"10.1016\/j.disamonth.2025.101853_bib0094","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1111\/j.1530-0277.2009.00960.x","article-title":"The impact of chronic cigarette smoking on recovery from cortical gray matter perfusion deficits in alcohol dependence: longitudinal arterial spin labeling MRI","volume":"33","author":"Mon","year":"2009","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.disamonth.2025.101853_bib0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.psychres.2022.114808","article-title":"Longitudinal resting-state functional connectivity changes in the insular subdivisions of abstinent individuals with opioid use disorder","volume":"317","author":"Yang","year":"2022","journal-title":"Psychiatry Res"},{"issue":"5","key":"10.1016\/j.disamonth.2025.101853_bib0096","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1111\/adb.12554","article-title":"Time-dependent neuronal changes associated with craving in opioid dependence: an fMRI study","volume":"23","author":"Murphy","year":"2018","journal-title":"Addict Biol"},{"issue":"4","key":"10.1016\/j.disamonth.2025.101853_bib0097","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1093\/brain\/awac366","article-title":"Common and distinct fronto-striatal volumetric changes in heroin and cocaine use disorders","volume":"146","author":"Ceceli","year":"2023","journal-title":"Brain"},{"key":"10.1016\/j.disamonth.2025.101853_bib0098","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.ajp.2019.02.009","article-title":"Risk, reversibility and resilience of brain circuitries linked to opioid dependence: a diffusion tensor imaging study of actively opioid-using subjects and three comparison groups","volume":"40","author":"Ghosh","year":"2019","journal-title":"Asian J Psychiatr"},{"issue":"5","key":"10.1016\/j.disamonth.2025.101853_bib0099","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1007\/s00406-020-01111-4","article-title":"Abnormal white matter within brain structural networks is associated with high-impulse behaviour in codeine-containing cough syrup dependent users","volume":"271","author":"Wu","year":"2021","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"issue":"6","key":"10.1016\/j.disamonth.2025.101853_bib0100","doi-asserted-by":"crossref","first-page":"2647","DOI":"10.1007\/s11682-022-00721-x","article-title":"Partial recovery of the left DLPFC-right insula circuit with reduced craving in abstinent heroin users: a longitudinal study","volume":"16","author":"Zhang","year":"2022","journal-title":"Brain Imaging Behav"},{"issue":"3","key":"10.1016\/j.disamonth.2025.101853_bib0101","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.bandc.2009.08.014","article-title":"Gray matter density negatively correlates with duration of heroin use in young lifetime heroin-dependent individuals","volume":"71","author":"Yuan","year":"2009","journal-title":"Brain Cogn"},{"issue":"2","key":"10.1016\/j.disamonth.2025.101853_bib0102","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1151\/spp07324","article-title":"Imaging the addicted human brain","volume":"3","author":"Fowler","year":"2007","journal-title":"Sci Pract Perspect"},{"issue":"4","key":"10.1016\/j.disamonth.2025.101853_bib0103","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.conb.2013.02.017","article-title":"Meta-analysis of structural brain abnormalities associated with stimulant drug dependence and neuroimaging of addiction vulnerability and resilience","volume":"23","author":"Ersche","year":"2013","journal-title":"Curr Opin Neurobiol"},{"issue":"4","key":"10.1016\/j.disamonth.2025.101853_bib0104","doi-asserted-by":"crossref","first-page":"290","DOI":"10.3109\/00952990.2015.1044607","article-title":"Gray matter abnormalities in cocaine versus methamphetamine-dependent patients: a neuroimaging meta-analysis","volume":"41","author":"Hall","year":"2015","journal-title":"Am J Drug Alcohol Abuse"},{"issue":"4","key":"10.1016\/j.disamonth.2025.101853_bib0105","doi-asserted-by":"crossref","first-page":"e12977","DOI":"10.1111\/adb.12977","article-title":"The role of withdrawal in mesocorticolimbic drug cue reactivity in opioid use disorder","volume":"26","author":"Shi","year":"2021","journal-title":"Addict Biol"},{"issue":"3","key":"10.1016\/j.disamonth.2025.101853_bib0106","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/nn1200","article-title":"Prefrontal responses to drug cues: a neurocognitive analysis","volume":"7","author":"Wilson","year":"2004","journal-title":"Nat Neurosci"},{"issue":"7","key":"10.1016\/j.disamonth.2025.101853_bib0107","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1111\/j.1460-9568.2010.07590.x","article-title":"Common biology of craving across legal and illegal drugs - a quantitative meta-analysis of cue-reactivity brain response","volume":"33","author":"K\u00fchn","year":"2011","journal-title":"Eur J Neurosci"},{"issue":"7","key":"10.1016\/j.disamonth.2025.101853_bib0108","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1001\/archpsyc.62.7.761","article-title":"Neural activation patterns of methamphetamine-dependent subjects during decision making predict relapse","volume":"62","author":"Paulus","year":"2005","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.disamonth.2025.101853_bib0109","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2023.101994","article-title":"Neurotransmitter systems in the etiology of major neurological disorders: emerging insights and therapeutic implications","volume":"89","author":"Nimgampalle","year":"2023","journal-title":"Ageing Res Rev"},{"issue":"1","key":"10.1016\/j.disamonth.2025.101853_bib0110","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1021\/acsami.2c02740","article-title":"Real-time monitoring of neurotransmitters in the brain of living animals","volume":"15","author":"Da","year":"2023","journal-title":"ACS Appl Mater Interfaces"},{"issue":"5","key":"10.1016\/j.disamonth.2025.101853_bib0111","doi-asserted-by":"crossref","first-page":"R154","DOI":"10.1016\/j.cub.2005.02.037","article-title":"Neurotransmitters","volume":"15","author":"Hyman","year":"2005","journal-title":"Curr Biol"},{"issue":"11","key":"10.1016\/j.disamonth.2025.101853_bib0112","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.1007\/s00216-015-9160-x","article-title":"Nanosensors for neurotransmitters","volume":"408","author":"Polo","year":"2016","journal-title":"Anal Bioanal Chem"},{"issue":"34","key":"10.1016\/j.disamonth.2025.101853_bib0113","doi-asserted-by":"crossref","DOI":"10.1002\/anie.202406401","article-title":"Imaging neurotransmitters with small-molecule fluorescent probes","volume":"63","author":"Bade","year":"2024","journal-title":"Angew Chem Int Ed Engl"},{"key":"10.1016\/j.disamonth.2025.101853_bib0114","series-title":"The Biogenic Amines","article-title":"Neuroscience","author":"Purves","year":"2001"},{"issue":"S280","key":"10.1016\/j.disamonth.2025.101853_bib0115","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/acps.1980.61.s280.75","article-title":"Seasonal and circadian monoamine variations in human brains examined post mortem","volume":"61","author":"Carlsson","year":"1980","journal-title":"Acta Psychiatr Scand"},{"issue":"1","key":"10.1016\/j.disamonth.2025.101853_bib0116","doi-asserted-by":"crossref","first-page":"137","DOI":"10.31887\/DCNS.2006.8.1\/acarlsson","article-title":"A dopaminergic deficit hypothesis of schizophrenia: the path to discovery","volume":"8","author":"Carlsson","year":"2006","journal-title":"Dialogues Clin Neurosci"},{"issue":"14","key":"10.1016\/j.disamonth.2025.101853_bib0117","doi-asserted-by":"crossref","first-page":"7529","DOI":"10.3390\/ijms25147529","article-title":"The role of dopamine neurotransmitters in neurological diseases: new sight","volume":"25","author":"Tian","year":"2024","journal-title":"Int J Mol Sci"},{"issue":"2","key":"10.1016\/j.disamonth.2025.101853_bib0118","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1177\/1073858411401413","article-title":"Dopaminergic neurotransmission in the human brain: new lessons from perturbation and imaging","volume":"18","author":"Ko","year":"2012","journal-title":"Neuroscientist"},{"issue":"3","key":"10.1016\/j.disamonth.2025.101853_bib0119","first-page":"331","article-title":"Neurotransmitters, psychotropic drugs and microglia: clinical implications for psychiatry","volume":"20","author":"Kato","year":"2013","journal-title":"Curr Med Chem"},{"issue":"11","key":"10.1016\/j.disamonth.2025.101853_bib0120","doi-asserted-by":"crossref","first-page":"e437","DOI":"10.1371\/journal.pmed.0030437","article-title":"The mechanistic classification of addictive drugs","volume":"3","author":"L\u00fcscher","year":"2006","journal-title":"PLoS Med"},{"key":"10.1016\/j.disamonth.2025.101853_bib0121","series-title":"StatPearls [Internet]","article-title":"Biochemistry, G protein coupled receptors","author":"Rehman","year":"2023"},{"issue":"1","key":"10.1016\/j.disamonth.2025.101853_bib0122","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1124\/pr.110.002642","article-title":"The physiology, signaling, and pharmacology of dopamine receptors","volume":"63","author":"Beaulieu","year":"2011","journal-title":"Pharmacol Rev"},{"issue":"12","key":"10.1016\/j.disamonth.2025.101853_bib0123","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1007\/s00018-010-0293-y","article-title":"The dopamine D4 receptor: biochemical and signalling properties","volume":"67","author":"Rondou","year":"2010","journal-title":"Cell Mol Life Sci"},{"issue":"2","key":"10.1016\/j.disamonth.2025.101853_bib0124","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1353\/pbm.2012.0017","article-title":"Earl Sutherland (1915-1974) [corrected] and the discovery of cyclic AMP","volume":"55","author":"Blumenthal","year":"2012","journal-title":"Perspect Biol Med"},{"key":"10.1016\/j.disamonth.2025.101853_bib0125","series-title":"StatPearls [Internet]","article-title":"Biochemistry, cAMP","author":"Patra","year":"2023"},{"key":"10.1016\/j.disamonth.2025.101853_bib0126","doi-asserted-by":"crossref","first-page":"152","DOI":"10.3389\/fncir.2013.00152","article-title":"Dopamine signaling in reward-related behaviors","volume":"7","author":"Baik","year":"2013","journal-title":"Front Neural Circuits"},{"key":"10.1016\/j.disamonth.2025.101853_bib0127","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neures.2016.01.004","article-title":"Neural mechanisms of the nucleus accumbens circuit in reward and aversive learning","volume":"108","author":"Hikida","year":"2016","journal-title":"Neurosci Res"},{"issue":"1","key":"10.1016\/j.disamonth.2025.101853_bib0128","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.bcp.2007.07.030","article-title":"Neurobiology of addiction. An integrative review","volume":"75","author":"Goodman","year":"2008","journal-title":"Biochem Pharmacol"},{"issue":"5","key":"10.1016\/j.disamonth.2025.101853_bib0129","doi-asserted-by":"crossref","first-page":"e13397","DOI":"10.1111\/adb.13397","article-title":"Nucleus accumbens neuronal ensembles vary with cocaine reinforcement in male and female rats","volume":"29","author":"Sortman","year":"2024","journal-title":"Addict Biol"},{"issue":"5","key":"10.1016\/j.disamonth.2025.101853_bib0130","doi-asserted-by":"crossref","first-page":"e13401","DOI":"10.1111\/adb.13401","article-title":"NMDA receptor within nucleus accumbens shell regulates propofol self-administration through D1R\/ERK\/CREB signalling pathway","volume":"29","author":"Li","year":"2024","journal-title":"Addict Biol"},{"key":"10.1016\/j.disamonth.2025.101853_bib0131","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2021.108600","article-title":"Ethanol inhibition of lateral orbitofrontal cortex neuron excitability is mediated via dopamine D1\/D5 receptor-induced release of astrocytic glycine","volume":"192","author":"Nimitvilai-Roberts","year":"2021","journal-title":"Neuropharmacology"},{"issue":"3","key":"10.1016\/j.disamonth.2025.101853_bib0132","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/0014-2999(88)90652-8","article-title":"Supersensitivity to a D-1 dopamine receptor agonist and subsensitivity to a D-2 receptor agonist following chronic D-1 receptor blockade","volume":"149","author":"Barone","year":"1988","journal-title":"Eur J Pharmacol"},{"issue":"16","key":"10.1016\/j.disamonth.2025.101853_bib0133","doi-asserted-by":"crossref","first-page":"6840","DOI":"10.1073\/pnas.0610790104","article-title":"Absence of dopamine D2 receptors unmasks an inhibitory control over the brain circuitries activated by cocaine","volume":"104","author":"Welter","year":"2007","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"8","key":"10.1016\/j.disamonth.2025.101853_bib0134","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1038\/nn1737","article-title":"PET imaging of dopamine D2 receptors during chronic cocaine self-administration in monkeys","volume":"9","author":"Nader","year":"2006","journal-title":"Nat Neurosci"},{"issue":"3","key":"10.1016\/j.disamonth.2025.101853_bib0135","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s002130000548","article-title":"Lack of operant ethanol self-administration in dopamine D2 receptor knockout mice","volume":"152","author":"Risinger","year":"2000","journal-title":"Psychopharmacology (Berl)"},{"issue":"12","key":"10.1016\/j.disamonth.2025.101853_bib0136","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1176\/appi.ajp.158.12.2015","article-title":"Low level of brain dopamine D2 receptors in methamphetamine abusers: association with metabolism in the orbitofrontal cortex","volume":"158","author":"Volkow","year":"2001","journal-title":"Am J Psychiatry"},{"issue":"6","key":"10.1016\/j.disamonth.2025.101853_bib0137","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1097\/01.ALC.0000171041.32716.42","article-title":"Dopamine D2 receptor availability is associated with subjective responses to alcohol","volume":"29","author":"Yoder","year":"2005","journal-title":"Alcohol Clin Exp Res"},{"issue":"1","key":"10.1016\/j.disamonth.2025.101853_bib0138","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1369-1600.2007.00051.x","article-title":"Evidence for the role of dopamine D3 receptors in oral operant alcohol self-administration and reinstatement of alcohol-seeking behavior in mice","volume":"12","author":"Heidbreder","year":"2007","journal-title":"Addict Biol"},{"issue":"2","key":"10.1016\/j.disamonth.2025.101853_bib0139","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1017\/S1461145705006449","article-title":"Selective antagonism at dopamine D3 receptors attenuates cocaine-seeking behaviour in the rat","volume":"10","author":"Cervo","year":"2007","journal-title":"Int J Neuropsychopharmacol"},{"issue":"1","key":"10.1016\/j.disamonth.2025.101853_bib0140","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0022-3565(24)35115-8","article-title":"Reinforcing effects of psychostimulants in humans are associated with increases in brain dopamine and occupancy of D(2) receptors","volume":"291","author":"Volkow","year":"1999","journal-title":"J Pharmacol Exp Ther"},{"issue":"18","key":"10.1016\/j.disamonth.2025.101853_bib0141","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1080\/14656566.2023.2266359","article-title":"The role of the D3 dopamine receptor and its partial agonist cariprazine in patients with schizophrenia and substance use disorder","volume":"24","author":"Grunze","year":"2023","journal-title":"Expert Opin Pharmacother"},{"issue":"6","key":"10.1016\/j.disamonth.2025.101853_bib0142","doi-asserted-by":"crossref","first-page":"e13424","DOI":"10.1111\/adb.13424","volume":"29","author":"Spitta","year":"2024","journal-title":"Addict Biol"},{"issue":"2","key":"10.1016\/j.disamonth.2025.101853_bib0143","doi-asserted-by":"crossref","first-page":"e13369","DOI":"10.1111\/adb.13369","article-title":"The dopamine 3 receptor as a candidate biomarker and therapeutic for opioid use disorder","author":"Banks","year":"2024","journal-title":"Addict Biol"},{"key":"10.1016\/j.disamonth.2025.101853_bib0144","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1159\/000324065","article-title":"Addiction and brain reward and antireward pathways","volume":"30","author":"Gardner","year":"2011","journal-title":"Adv Psychosom Med"},{"issue":"1","key":"10.1016\/j.disamonth.2025.101853_bib0145","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0091-3057(97)00047-6","article-title":"A two-separate-motivational-systems hypothesis of opioid addiction","volume":"59","author":"Bechara","year":"1998","journal-title":"Pharmacol Biochem Behav"},{"issue":"1","key":"10.1016\/j.disamonth.2025.101853_bib0146","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/0006-8993(91)90690-W","article-title":"Effect of dose on cocaine self-administration behavior and dopamine levels in the nucleus accumbens","volume":"539","author":"Pettit","year":"1991","journal-title":"Brain Res"},{"issue":"1","key":"10.1016\/j.disamonth.2025.101853_bib0147","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1037\/0735-7044.119.1.5","article-title":"Distinguishing whether dopamine regulates liking, wanting, and\/or learning about rewards","volume":"119","author":"Robinson","year":"2005","journal-title":"Behav Neurosci"},{"issue":"8","key":"10.1016\/j.disamonth.2025.101853_bib0148","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1176\/appi.ajp.162.8.1414","article-title":"Addiction: a disease of learning and memory","volume":"162","author":"Hyman","year":"2005","journal-title":"Am J Psychiatry"},{"issue":"5","key":"10.1016\/j.disamonth.2025.101853_bib0149","doi-asserted-by":"crossref","DOI":"10.1056\/NEJM195907302610505","article-title":"Serotonin","volume":"261","author":"Sjoerdsma","year":"1959","journal-title":"N Engl J Med"},{"key":"10.1016\/j.disamonth.2025.101853_bib0150","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2023.1200370","article-title":"Expanding the concept of serotoninomics: perspectives for serotonin studies in the 20\u2032s of the 21st century","volume":"17","author":"Jim\u00e9nez-Trejo","year":"2023","journal-title":"Front Neurosci"},{"issue":"10","key":"10.1016\/j.disamonth.2025.101853_bib0151","doi-asserted-by":"crossref","first-page":"3125","DOI":"10.1111\/j.1460-9568.2007.05568.x","article-title":"5-HT(1B) receptors in nucleus accumbens efferents enhance both rewarding and aversive effects of cocaine","volume":"25","author":"Barot","year":"2007","journal-title":"Eur J Neurosci"},{"issue":"5","key":"10.1016\/j.disamonth.2025.101853_bib0152","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1111\/j.1471-4159.2006.04163.x","article-title":"Biphasic alterations in serotonin-1B (5-HT1B) receptor function during abstinence from extended cocaine self-administration","volume":"99","author":"O'Dell","year":"2006","journal-title":"J Neurochem"},{"issue":"2","key":"10.1016\/j.disamonth.2025.101853_bib0153","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/ajmg.b.32128","article-title":"Associations of the 5-hydroxytryptamine (serotonin) receptor 1B gene (HTR1B) with alcohol, cocaine, and heroin abuse","volume":"162B","author":"Cao","year":"2013","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"issue":"8","key":"10.1016\/j.disamonth.2025.101853_bib0154","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1007\/s00213-022-06141-5","article-title":"Methylation and expression quantitative trait locus rs6296 in the HTR1B gene is associated with susceptibility to opioid use disorder","volume":"239","author":"Li","year":"2022","journal-title":"Psychopharmacology (Berl)"},{"issue":"1","key":"10.1016\/j.disamonth.2025.101853_bib0155","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1097\/01.fpc.0000182782.87932.d6","article-title":"Association analysis of polymorphisms in serotonin 1B receptor (HTR1B) gene with heroin addiction: a comparison of molecular and statistically estimated haplotypes","volume":"16","author":"Proudnikov","year":"2006","journal-title":"Pharmacogenet Genomics"},{"key":"10.1016\/j.disamonth.2025.101853_bib0156","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.bbr.2014.04.007","article-title":"The role of serotonin in drug use and addiction","volume":"277","author":"M\u00fcller","year":"2015","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.disamonth.2025.101853_bib0157","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/7854_2023_452","article-title":"Mechanisms of SSRI therapy and discontinuation","volume":"66","author":"Sharp","year":"2024","journal-title":"Curr Top Behav Neurosci"},{"key":"10.1016\/j.disamonth.2025.101853_bib0158","series-title":"StatPearls [Internet]","article-title":"Selective Serotonin Reuptake Inhibitors","author":"Chu","year":"2023"},{"issue":"7","key":"10.1016\/j.disamonth.2025.101853_bib0159","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1111\/jcpp.13926","article-title":"Substance use outcomes from the Child\/Adolescent Anxiety Multimodal Extended Long-term Study (CAMELS)","volume":"65","author":"Rabner","year":"2024","journal-title":"J Child Psychol Psychiatry"},{"issue":"6","key":"10.1016\/j.disamonth.2025.101853_bib0160","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1007\/s00228-022-03303-4","article-title":"Selective serotonin reuptake inhibitors in the treatment of depression, anxiety, and post-traumatic stress disorder in substance use disorders: a Bayesian meta-analysis","volume":"78","author":"Fluyau","year":"2022","journal-title":"Eur J Clin Pharmacol"},{"issue":"7","key":"10.1016\/j.disamonth.2025.101853_bib0161","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1038\/sj.npp.1301263","article-title":"There and back again: a tale of norepinephrine and drug addiction","volume":"32","author":"Weinshenker","year":"2007","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.disamonth.2025.101853_bib0162","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.neulet.2014.11.019","article-title":"The involvement of norepinephrine in pain modulation in the nucleus accumbens of morphine-dependent rats","volume":"585","author":"Zhang","year":"2015","journal-title":"Neurosci Lett"},{"issue":"1","key":"10.1016\/j.disamonth.2025.101853_bib0163","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.bcp.2007.08.003","article-title":"Monoamine transporters and psychostimulant addiction","volume":"75","author":"Howell","year":"2008","journal-title":"Biochem Pharmacol"},{"issue":"3","key":"10.1016\/j.disamonth.2025.101853_bib0164","doi-asserted-by":"crossref","first-page":"407","DOI":"10.2174\/1570159X13666150121225659","article-title":"The involvement of norepinephrine in behaviors related to psychostimulant addiction","volume":"13","author":"Zaniewska","year":"2015","journal-title":"Curr Neuropharmacol"},{"key":"10.1016\/j.disamonth.2025.101853_bib0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2021.108814","article-title":"Corticotropin releasing factor and norepinephrine related circuitry changes in the bed nucleus of the stria terminalis in stress and alcohol and substance use disorders","volume":"201","author":"Snyder","year":"2021","journal-title":"Neuropharmacology"},{"issue":"1","key":"10.1016\/j.disamonth.2025.101853_bib0166","doi-asserted-by":"crossref","first-page":"e12864","DOI":"10.1111\/adb.12864","article-title":"Nicotine, cocaine, amphetamine, morphine, and ethanol increase norepinephrine output in the bed nucleus of stria terminalis of freely moving rats","author":"Jadzic","year":"2021","journal-title":"Addict Biol"},{"issue":"Pt B","key":"10.1016\/j.disamonth.2025.101853_bib0167","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.brainres.2016.01.005","article-title":"Norepinephrine versus dopamine and their interaction in modulating synaptic function in the prefrontal cortex","volume":"1641","author":"Xing","year":"2016","journal-title":"Brain Res"},{"key":"10.1016\/j.disamonth.2025.101853_bib0168","doi-asserted-by":"crossref","DOI":"10.1016\/j.pnpbp.2024.111055","article-title":"Adolescent stress differentially modifies dopamine and norepinephrine release in the medial prefrontal cortex of adult rats","volume":"134","author":"Carboni","year":"2024","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"19","key":"10.1016\/j.disamonth.2025.101853_bib0169","doi-asserted-by":"crossref","first-page":"7476","DOI":"10.1073\/pnas.0600839103","article-title":"Behavioral sensitization to amphetamine results from an uncoupling between noradrenergic and serotonergic neurons","volume":"103","author":"Salomon","year":"2006","journal-title":"Proc Natl Acad Sci U S A."},{"key":"10.1016\/j.disamonth.2025.101853_bib0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115800","article-title":"Current status of GABA receptor subtypes in analgesia","volume":"168","author":"Qian","year":"2023","journal-title":"Biomed Pharmacother"},{"issue":"6","key":"10.1016\/j.disamonth.2025.101853_bib0171","first-page":"755","article-title":"GABA(B) receptors in drug addiction","volume":"60","author":"Filip","year":"2008","journal-title":"Pharmacol Rep"},{"key":"10.1016\/j.disamonth.2025.101853_bib0172","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/7854_2020_187","article-title":"GABAB Receptors and drug addiction: psychostimulants and other drugs of abuse","volume":"52","author":"Li","year":"2022","journal-title":"Curr Top Behav Neurosci"},{"issue":"1\u20132","key":"10.1016\/j.disamonth.2025.101853_bib0173","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1007\/s002130050695","article-title":"Blocking GABA(A) receptors in the anterior ventral tegmental area attenuates ethanol intake of the alcohol-preferring P rat","volume":"139","author":"Nowak","year":"1998","journal-title":"Psychopharmacology (Berl)"},{"issue":"1","key":"10.1016\/j.disamonth.2025.101853_bib0174","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/0091-3057(93)90338-T","article-title":"Bidirectional effects of GABAergic agonists and antagonists on maintenance of voluntary ethanol intake in rats","volume":"46","author":"Boyle","year":"1993","journal-title":"Pharmacol Biochem Behav"},{"issue":"12","key":"10.1016\/j.disamonth.2025.101853_bib0175","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1038\/s41401-018-0180-x","article-title":"Drug addiction: a curable mental disorder?","volume":"39","author":"Liu","year":"2018","journal-title":"Acta Pharmacol Sin"},{"key":"10.1016\/j.disamonth.2025.101853_bib0176","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.coph.2014.12.001","article-title":"Dynamics and modulation of metabotropic glutamate receptors","volume":"20","author":"Rondard","year":"2015","journal-title":"Curr Opin Pharmacol"},{"key":"10.1016\/j.disamonth.2025.101853_bib0177","doi-asserted-by":"crossref","first-page":"264","DOI":"10.3389\/fncel.2016.00264","article-title":"Presynaptic G protein-coupled receptors: gatekeepers of addiction?","volume":"10","author":"Johnson","year":"2016","journal-title":"Front Cell Neurosci"},{"issue":"4","key":"10.1016\/j.disamonth.2025.101853_bib0178","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1073\/pnas.1416196112","article-title":"Metabotropic glutamate receptor 3 activation is required for long-term depression in medial prefrontal cortex and fear extinction","volume":"112","author":"Walker","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"10.1016\/j.disamonth.2025.101853_bib0179","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1097\/WNR.0000000000001760","article-title":"The distinct roles of various neurotransmitters in modulating methamphetamine-induced conditioned place preference in relevant brain regions in mice","volume":"33","author":"Su","year":"2022","journal-title":"Neuroreport"},{"key":"10.1016\/j.disamonth.2025.101853_bib0180","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2023.1165261","article-title":"SNAP25 differentially contributes to Gi\/o-coupled receptor function at glutamatergic synapses in the nucleus accumbens","volume":"17","author":"Manz","year":"2023","journal-title":"Front Cell Neurosci"},{"key":"10.1016\/j.disamonth.2025.101853_bib0181","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.ejphar.2018.07.039","article-title":"Endocannabinoid system, stress and HPA axis","volume":"834","author":"Micale","year":"2018","journal-title":"Eur J Pharmacol"},{"issue":"1\u20133","key":"10.1016\/j.disamonth.2025.101853_bib0182","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.drugalcdep.2012.12.005","article-title":"Adult hippocampal neurogenesis in the pathogenesis of addiction and dual diagnosis disorders","volume":"130","author":"Chambers","year":"2013","journal-title":"Drug Alcohol Depend"},{"issue":"2","key":"10.1016\/j.disamonth.2025.101853_bib0183","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/j.1369-1600.2008.00109.x","article-title":"The role of CB1 receptors in psychostimulant addiction","volume":"13","author":"Wiskerke","year":"2008","journal-title":"Addict Biol"},{"issue":"3","key":"10.1016\/j.disamonth.2025.101853_bib0184","doi-asserted-by":"crossref","first-page":"187","DOI":"10.2174\/156802608783498014","article-title":"Recent advances in the development of selective ligands for the cannabinoid CB(2) receptor","volume":"8","author":"Marriott","year":"2008","journal-title":"Curr Top Med Chem"},{"key":"10.1016\/j.disamonth.2025.101853_bib0185","series-title":"Normal Child and Adolescent Psychological Development","first-page":"21","author":"Pancost","year":"2022"},{"issue":"2","key":"10.1016\/j.disamonth.2025.101853_bib0186","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/1467-8721.00010","article-title":"Neural plasticity and human development","volume":"8","author":"Nelson","year":"1999","journal-title":"Curr Dir Psychol Sci"},{"issue":"1","key":"10.1016\/j.disamonth.2025.101853_bib0187","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/jora.12408","article-title":"Understanding the role of puberty in structural and functional development of the adolescent brain","volume":"29","author":"Goddings","year":"2019","journal-title":"J Res Adolesc"},{"issue":"3\u20134","key":"10.1016\/j.disamonth.2025.101853_bib0188","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1111\/j.1469-7610.2006.01611.x","article-title":"Development of the adolescent brain: implications for executive function and social cognition","volume":"47","author":"Blakemore","year":"2006","journal-title":"J Child Psychol Psychiatry"},{"issue":"1","key":"10.1016\/j.disamonth.2025.101853_bib0189","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1080\/17470210701508715","article-title":"Development of the social brain during adolescence","volume":"61","author":"Blakemore","year":"2008","journal-title":"Q J Exp Psychol (Hove)"},{"issue":"2","key":"10.1016\/j.disamonth.2025.101853_bib0190","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.neuroimage.2011.11.080","article-title":"Imaging brain development: the adolescent brain","volume":"61","author":"Blakemore","year":"2012","journal-title":"Neuroimage"},{"issue":"2","key":"10.1016\/j.disamonth.2025.101853_bib0191","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.conb.2007.03.009","article-title":"Emotional and cognitive changes during adolescence","volume":"17","author":"Yurgelun-Todd","year":"2007","journal-title":"Curr Opin Neurobiol"},{"key":"10.1016\/j.disamonth.2025.101853_bib0192","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2024.1365737","article-title":"How the forebrain transitions to adulthood: developmental plasticity markers in a long-lived rodent reveal region diversity and the uniqueness of adolescence","volume":"18","author":"Gardu\u00f1o","year":"2024","journal-title":"Front Neurosci"},{"key":"10.1016\/j.disamonth.2025.101853_bib0193","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a041502","article-title":"Development of prefrontal circuits and cognitive abilities","author":"P\u00f6pplau","year":"2024","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"3","key":"10.1016\/j.disamonth.2025.101853_bib0194","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuron.2023.10.024","article-title":"Reorganization of adolescent prefrontal cortex circuitry is required for mouse cognitive maturation","volume":"112","author":"P\u00f6pplau","year":"2024","journal-title":"Neuron"},{"issue":"1","key":"10.1016\/j.disamonth.2025.101853_bib0195","doi-asserted-by":"crossref","first-page":"7987","DOI":"10.1038\/s41467-024-52366-7","article-title":"IMAGEN Consortium; Nees F, Banaschewski T, Eickhoff SB, Dukart J. Regional patterns of human cortex development correlate with underlying neurobiology","volume":"15","author":"Lotter","year":"2024","journal-title":"Nat Commun"},{"key":"10.1016\/j.disamonth.2025.101853_bib0196","doi-asserted-by":"crossref","DOI":"10.1016\/j.pbb.2024.173766","article-title":"Unlocking the age-old secrets of reward and substance use","volume":"239","author":"Liu","year":"2024","journal-title":"Pharmacol Biochem Behav"},{"issue":"7","key":"10.1016\/j.disamonth.2025.101853_bib0197","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1038\/s41380-024-02471-2","article-title":"Adolescent substance use initiation and long-term neurobiological outcomes: insights, challenges and opportunities","volume":"29","author":"Boer","year":"2024","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.disamonth.2025.101853_bib0198","series-title":"StatPearls [Internet]","article-title":"Biochemistry, Endogenous Opioids","author":"Shenoy","year":"2024"},{"key":"10.1016\/j.disamonth.2025.101853_bib0199","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2022.919773","article-title":"Opioid receptor-mediated regulation of neurotransmission in the brain","volume":"15","author":"Reeves","year":"2022","journal-title":"Front Mol Neurosci"},{"issue":"1","key":"10.1016\/j.disamonth.2025.101853_bib0200","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1177\/2049463712438493","article-title":"Basic opioid pharmacology: an update","volume":"6","author":"Pathan","year":"2012","journal-title":"Br J Pain"},{"issue":"19","key":"10.1016\/j.disamonth.2025.101853_bib0201","doi-asserted-by":"crossref","first-page":"7262","DOI":"10.1523\/JNEUROSCI.23-19-07262.2003","article-title":"Presynaptic mechanism for anti-analgesic and anti-hyperalgesic actions of kappa-opioid receptors","volume":"23","author":"Bie","year":"2003","journal-title":"J Neurosci"},{"key":"10.1016\/j.disamonth.2025.101853_bib0202","article-title":"Delta opioid receptors engage multiple signaling cascades to differentially modulate prefrontal GABA release with input and target specificity","author":"Alexander","year":"2024","journal-title":"bioRxiv [Preprint]"},{"key":"10.1016\/j.disamonth.2025.101853_bib0203","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.837671","article-title":"The Kappa opioid receptor: a promising therapeutic target for multiple pathologies","volume":"13","author":"Dalefield","year":"2022","journal-title":"Front Pharmacol"},{"issue":"2","key":"10.1016\/j.disamonth.2025.101853_bib0204","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1177\/2049463720911986","article-title":"Basic opioid pharmacology - An update","volume":"14","author":"James","year":"2020","journal-title":"Br J Pain"},{"key":"10.1016\/j.disamonth.2025.101853_bib0205","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/164_2018_195","article-title":"The history of N\/OFQ and the NOP receptor","volume":"254","author":"Reinscheid","year":"2019","journal-title":"Handb Exp Pharmacol"},{"key":"10.1016\/j.disamonth.2025.101853_bib0206","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2024.109866","article-title":"Pharmacological blockage of NOP receptors decreases ventral tegmental area dopamine neuronal activity through GABAB receptor-mediated mechanism","volume":"248","author":"Petrella","year":"2024","journal-title":"Neuropharmacology"},{"issue":"2","key":"10.1016\/j.disamonth.2025.101853_bib0207","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1124\/jpet.123.002052","article-title":"Pharmacologic characterization of substituted nitazenes at \u03bc, \u03ba, and \u0394 opioid receptors suggests high potential for toxicity","volume":"389","author":"Kozell","year":"2024","journal-title":"J Pharmacol Exp Ther"},{"issue":"6","key":"10.1016\/j.disamonth.2025.101853_bib0208","first-page":"e40736","article-title":"Old drugs and new challenges: a narrative review of nitazenes","volume":"15","author":"Pergolizzi","year":"2023","journal-title":"Cureus"},{"issue":"12","key":"10.1016\/j.disamonth.2025.101853_bib0209","doi-asserted-by":"crossref","first-page":"2573","DOI":"10.1007\/s00213-023-06451-2","article-title":"Alkoxy chain length governs the potency of 2-benzylbenzimidazole 'nitazene' opioids associated with human overdose","volume":"240","author":"Glatfelter","year":"2023","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.disamonth.2025.101853_bib0210","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1434573","article-title":"Metabolic characterization of the new benzimidazole synthetic opioids - nitazenes","volume":"15","author":"Jadhav","year":"2024","journal-title":"Front Pharmacol"},{"issue":"15","key":"10.1016\/j.disamonth.2025.101853_bib0211","first-page":"7337","article-title":"Pharmacology and toxicology of xylazine: quid novum?","volume":"27","author":"Malaca","year":"2023","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"1","key":"10.1016\/j.disamonth.2025.101853_bib0212","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1097\/PAF.0000000000000622","article-title":"Xylazine, a veterinary tranquilizer, detected in 42 accidental fentanyl intoxication deaths","volume":"42","author":"Nunez","year":"2021","journal-title":"Am J Forensic Med Pathol"},{"issue":"11","key":"10.1016\/j.disamonth.2025.101853_bib0213","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1021\/acschemneuro.4c00172","article-title":"Classics in chemical neuroscience: xylazine","volume":"15","author":"Hoffman","year":"2024","journal-title":"ACS Chem Neurosci"},{"issue":"6","key":"10.1016\/j.disamonth.2025.101853_bib0214","doi-asserted-by":"crossref","first-page":"760","DOI":"10.5498\/wjp.v14.i6.760","article-title":"Fentanyl and xylazine crisis: crafting coherent strategies for opioid overdose prevention","volume":"14","author":"Jain","year":"2024","journal-title":"World J Psychiatry"},{"issue":"21","key":"10.1016\/j.disamonth.2025.101853_bib0215","doi-asserted-by":"crossref","first-page":"3874","DOI":"10.1021\/acschemneuro.4c00583","article-title":"Classics in chemical neuroscience: medetomidine","volume":"15","author":"de Andrade Horn","year":"2024","journal-title":"ACS Chem Neurosci"},{"issue":"1","key":"10.1016\/j.disamonth.2025.101853_bib0216","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/s002130000425","article-title":"Anatomical and pharmacological specificity of the rewarding effect elicited by microinjections of morphine into the nucleus accumbens of mice","volume":"150","author":"David","year":"2000","journal-title":"Psychopharmacology (Berl.)"},{"issue":"2","key":"10.1016\/j.disamonth.2025.101853_bib0217","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.bbr.2007.03.014","article-title":"Morphine self-administration into the lateral septum depends on dopaminergic mechanisms: evidence from pharmacology and Fos neuroimaging","volume":"180","author":"Le Merrer","year":"2007","journal-title":"Behav Brain Res"},{"issue":"3","key":"10.1016\/j.disamonth.2025.101853_bib0218","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/0091-3057(85)90027-9","article-title":"Effects of intracerebroventricular administration of methyl naloxonium chloride on heroin self-administration in the rat","volume":"23","author":"Vaccarino","year":"1985","journal-title":"Pharmacol Biochem Behav"},{"issue":"2","key":"10.1016\/j.disamonth.2025.101853_bib0219","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1523\/JNEUROSCI.12-02-00483.1992","article-title":"Opioids excite dopamine neurons by hyperpolarization of local interneurons","volume":"12","author":"Johnson","year":"1992","journal-title":"J Neurosci"},{"issue":"11","key":"10.1016\/j.disamonth.2025.101853_bib0220","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/j.tips.2016.08.002","article-title":"Allostatic mechanisms of opioid tolerance beyond desensitization and downregulation","volume":"37","author":"Cahill","year":"2016","journal-title":"Trends Pharmacol Sci"},{"issue":"14","key":"10.1016\/j.disamonth.2025.101853_bib0221","doi-asserted-by":"crossref","first-page":"5260","DOI":"10.2741\/3596","article-title":"Mechanisms underlying morphine analgesic tolerance and dependence","volume":"14","author":"Ueda","year":"2009","journal-title":"Front Biosci (Landmark Ed)"},{"issue":"6","key":"10.1016\/j.disamonth.2025.101853_bib0222","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.tips.2014.04.002","article-title":"Dopamine ups and downs in vulnerability to addictions: a neurodevelopmental model","author":"Leyton","year":"2014","journal-title":"Trends Pharmacol Sci"},{"issue":"10","key":"10.1016\/j.disamonth.2025.101853_bib0223","doi-asserted-by":"crossref","first-page":"2494","DOI":"10.1038\/sj.npp.1301634","article-title":"Tolerance to repeated morphine administration is associated with increased potency of opioid agonists","volume":"33","author":"Ingram","year":"2008","journal-title":"Neuropsychopharmacology"},{"issue":"6","key":"10.1016\/j.disamonth.2025.101853_bib0224","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1007\/s11010-023-04810-3","article-title":"Molecular mechanisms of morphine tolerance and dependence; novel insights and future perspectives","volume":"479","author":"Badshah","year":"2024","journal-title":"Mol Cell Biochem"},{"issue":"6","key":"10.1016\/j.disamonth.2025.101853_bib0225","doi-asserted-by":"crossref","DOI":"10.1523\/JNEUROSCI.1368-23.2023","article-title":"Opioid-induced hyperalgesia and tolerance are driven by HCN ion channels","volume":"44","author":"Han","year":"2024","journal-title":"J Neurosci"},{"issue":"22","key":"10.1016\/j.disamonth.2025.101853_bib0226","doi-asserted-by":"crossref","first-page":"RC110","DOI":"10.1523\/JNEUROSCI.20-22-j0007.2000","article-title":"Heterodimerization of mu and delta opioid receptors: a role in opiate synergy","volume":"20","author":"Gomes","year":"2000","journal-title":"J Neurosci"},{"issue":"1","key":"10.1016\/j.disamonth.2025.101853_bib0227","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1097\/j.pain.0000000000002320","article-title":"Antagonism of the mu-delta opioid receptor heterodimer enhances opioid antinociception by activating Src and calcium\/calmodulin-dependent protein kinase II signaling","volume":"163","author":"Keresztes","year":"2022","journal-title":"Pain"},{"key":"10.1016\/j.disamonth.2025.101853_bib0228","series-title":"Behavioral Pediatrics. Mental Health and Management","first-page":"213","article-title":"Psychosocial treatments","author":"Ather","year":"2022"},{"issue":"6","key":"10.1016\/j.disamonth.2025.101853_bib0229","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1097\/01.chi.0000159135.33706.37","article-title":"Work Group on Quality Issues. Practice parameter for the assessment and treatment of children and adolescents with substance use disorders","volume":"44","author":"Bukstein","year":"2005","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"10","key":"10.1016\/j.disamonth.2025.101853_bib0230","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1001\/archpsyc.62.10.1157","article-title":"Comparison of pharmacological treatments for opioid-dependent adolescents: a randomized controlled trial","volume":"62","author":"Marsch","year":"2005","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.disamonth.2025.101853_bib0231","series-title":"StatPearls [Internet]","article-title":"Cognitive behavior therapy","author":"Chand","year":"2023"},{"issue":"1","key":"10.1016\/j.disamonth.2025.101853_bib0232","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1186\/s12888-024-05556-y","article-title":"Systemic therapy in children and adolescents with mental disorders: a systematic review and meta-analysis","volume":"24","author":"Seidel","year":"2024","journal-title":"BMC Psychiatry"},{"issue":"5","key":"10.1016\/j.disamonth.2025.101853_bib0233","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s00702-023-02720-8","article-title":"Psychotherapies in opioid use disorder: toward a step-care model","volume":"131","author":"Durpoix","year":"2024","journal-title":"J Neural Transm (Vienna)"},{"issue":"1","key":"10.1016\/j.disamonth.2025.101853_bib0234","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1186\/s12888-024-05913-x","article-title":"Before, we ended up in conflicts, now we can provide support'-Experiences of Community Reinforcement and Family Training (CRAFT) for parents of young adults with hazardous substance use","volume":"24","author":"Siljeholm","year":"2024","journal-title":"BMC Psychiatry"},{"issue":"1","key":"10.1016\/j.disamonth.2025.101853_bib0235","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s13722-024-00437-x","article-title":"Provider perceptions of systems-level barriers and facilitators to utilizing family-based treatment approaches in adolescent and young adult opioid use disorder treatment","volume":"19","author":"Pielech","year":"2024","journal-title":"Addict Sci Clin Pract"},{"issue":"9","key":"10.1016\/j.disamonth.2025.101853_bib0236","doi-asserted-by":"crossref","DOI":"10.1016\/j.disamonth.2024.101725","article-title":"Pediatric suicide: review of a preventable tragedy","volume":"70","author":"Greydanus","year":"2024","journal-title":"Dis Mon"},{"issue":"3","key":"10.1016\/j.disamonth.2025.101853_bib0237","doi-asserted-by":"crossref","DOI":"10.1016\/j.disamonth.2023.101631","article-title":"Health equity in pediatrics: current concepts for the care of children in the 21st century","volume":"70","author":"Dickson","year":"2024","journal-title":"Dis Mon."},{"key":"10.1016\/j.disamonth.2025.101853_bib0238","series-title":"StatPearls [Internet]","article-title":"Morrisonponce D. Naloxone","author":"Jordan","year":"2024"},{"issue":"4","key":"10.1016\/j.disamonth.2025.101853_bib0239","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1080\/10903127.2020.1810372","article-title":"Public Health Committee on behalf of the NAEMSP Board of Directors. The role of emergency medical services in the opioid epidemic","volume":"25","author":"Joiner","year":"2021","journal-title":"Prehosp Emerg Care"},{"issue":"4","key":"10.1016\/j.disamonth.2025.101853_bib0240","doi-asserted-by":"crossref","first-page":"270","DOI":"10.56808\/2586-940X.1045","article-title":"A qualitative analysis of emergency medical services (EMS) personnel experiences and perceptions responding to drug overdoses in the United States (US) during the COVID-19 pandemic","volume":"37","author":"Won","year":"2023","journal-title":"J Health Res"},{"issue":"1","key":"10.1016\/j.disamonth.2025.101853_bib0241","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s12954-024-00957-4","article-title":"An evaluation of first responders' intention to refer to post-overdose services following SHIELD training","volume":"21","author":"Siddiqui","year":"2024","journal-title":"Harm Reduct J"},{"issue":"1","key":"10.1016\/j.disamonth.2025.101853_bib0242","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/s12954-022-00682-w","article-title":"Naloxone administration by law enforcement officers in New York State (2015-2020)","volume":"19","author":"Pourtaher","year":"2022","journal-title":"Harm Reduct J"},{"issue":"1","key":"10.1016\/j.disamonth.2025.101853_bib0243","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s12954-023-00748-3","article-title":"It's just another tool on my toolbelt\": new York state law enforcement officer experiences administering naloxone","volume":"20","author":"Lloyd","year":"2023","journal-title":"Harm Reduct J"},{"issue":"15","key":"10.1016\/j.disamonth.2025.101853_bib0244","doi-asserted-by":"crossref","first-page":"3999","DOI":"10.1007\/s11606-022-07689-w","article-title":"The case for mobile \"Street Medicine\" for patients experiencing homelessness","volume":"37","author":"Lynch","year":"2022","journal-title":"J Gen Intern Med"},{"issue":"6","key":"10.1016\/j.disamonth.2025.101853_bib0245","doi-asserted-by":"crossref","first-page":"760","DOI":"10.3390\/ijerph21060760","article-title":"The role of street medicine and mobile clinics for persons experiencing homelessness: a scoping review","volume":"21","author":"Kaufman","year":"2024","journal-title":"Int J Environ Res Public Health"},{"issue":"1","key":"10.1016\/j.disamonth.2025.101853_bib0246","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1186\/s12889-024-19596-2","article-title":"They made me feel like I mattered\": a qualitative study of how mobile crisis teams can support people experiencing homelessness","volume":"24","author":"McDaniel","year":"2024","journal-title":"BMC Public Health"},{"issue":"4","key":"10.1016\/j.disamonth.2025.101853_bib0247","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1017\/S0963180121000116","article-title":"The birth of naloxone: an intellectual history of an ambivalent opioid","volume":"30","author":"Kolbe","year":"2021","journal-title":"Camb Q Healthc Ethics"},{"key":"10.1016\/j.disamonth.2025.101853_bib0248","series-title":"StatPearls [Internet]","article-title":"Opioid overdose","author":"Schiller","year":"2023"},{"issue":"2","key":"10.1016\/j.disamonth.2025.101853_bib0249","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/ajad.12862","article-title":"Review article: effective management of opioid withdrawal symptoms: a gateway to opioid dependence treatment","volume":"28","author":"Kosten","year":"2019","journal-title":"Am J Addict"},{"issue":"12","key":"10.1016\/j.disamonth.2025.101853_bib0250","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1001\/jama.2024.13626","article-title":"Increasing mortality rates in the US but not from COVID-19","volume":"332","author":"Woolf","year":"2024","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.disamonth.2025.101853_bib0251","doi-asserted-by":"crossref","DOI":"10.7196\/SARJ.2019.v25i3.001","article-title":"Organophosphate poisoning at Chris Hani Baragwanath Academic Hospital 2012 - 2015","volume":"25","author":"Bruins","year":"2019","journal-title":"Afr J Thorac Crit Care Med"},{"issue":"1","key":"10.1016\/j.disamonth.2025.101853_bib0252","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/1865-1380-4-32","article-title":"Accidental organophosphate insecticide intoxication in children: a reminder","volume":"4","author":"van Heel","year":"2011","journal-title":"Int J Emerg Med"},{"issue":"1","key":"10.1016\/j.disamonth.2025.101853_bib0253","first-page":"19","article-title":"Pin-point pupils with drowsiness as a presentation of Hashimoto's encephalopathy mimicking pontine infarction","volume":"23","author":"Yeh","year":"2014","journal-title":"Acta Neurol Taiwan"},{"issue":"2","key":"10.1016\/j.disamonth.2025.101853_bib0254","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1213\/01.ANE.0000227206.33424.EF","article-title":"Unresponsiveness and pinpoint pupils after cerebellopontine angle tumor resection: opioid overdose versus postoperative hemorrhage","volume":"103","author":"Khan","year":"2006","journal-title":"Anesth Analg"},{"issue":"4","key":"10.1016\/j.disamonth.2025.101853_bib0255","doi-asserted-by":"crossref","first-page":"e29","DOI":"10.1136\/emj.2005.031690","article-title":"Pontine haemorrhage mimicked by an olanzapine overdose","volume":"23","author":"Broyd","year":"2006","journal-title":"Emerg Med J"},{"issue":"2","key":"10.1016\/j.disamonth.2025.101853_bib0256","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1177\/096032719000900209","article-title":"Zolpidem intoxication mimicking narcotic overdose: response to flumazenil","volume":"9","author":"Lheureux","year":"1990","journal-title":"Hum Exp Toxicol"},{"issue":"8","key":"10.1016\/j.disamonth.2025.101853_bib0257","first-page":"952","article-title":"Poisoning necessitating pediatric ICU admissions: size of pupils does matter","volume":"100","author":"Hon","year":"2008","journal-title":"J Natl Med Assoc"},{"key":"10.1016\/j.disamonth.2025.101853_bib0258","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jcrc.2016.04.022","article-title":"Opioid overdose leading to intensive care unit admission: epidemiology and outcomes","volume":"35","author":"Pfister","year":"2016","journal-title":"J Crit Care"},{"issue":"3","key":"10.1016\/j.disamonth.2025.101853_bib0259","doi-asserted-by":"crossref","first-page":"271","DOI":"10.5114\/ait.2022.118881","article-title":"Are we ready to manage an opioid epidemic in the intensive care unit?","volume":"54","author":"Das","year":"2022","journal-title":"Anaesthesiol Intensive Ther"},{"issue":"3","key":"10.1016\/j.disamonth.2025.101853_bib0260","doi-asserted-by":"crossref","first-page":"e380","DOI":"10.1097\/MJT.0000000000000681","article-title":"Acute opiate overdose: an update on management strategies in emergency department and critical care unit","volume":"26","author":"Parthvi","year":"2019","journal-title":"Am J Ther"},{"issue":"10","key":"10.1016\/j.disamonth.2025.101853_bib0261","doi-asserted-by":"crossref","first-page":"2575","DOI":"10.1007\/s00204-023-03563-8","article-title":"Neonatal opioid toxicity: opioid withdrawal (abstinence) syndrome with emphasis on pharmacogenomics and respiratory depression","volume":"97","author":"Baldo","year":"2023","journal-title":"Arch Toxicol"},{"key":"10.1016\/j.disamonth.2025.101853_bib0262","series-title":"StatPearls [Internet]","article-title":"Opioid withdrawal. 2023 Jul 21","author":"Shah","year":"2024"},{"issue":"1","key":"10.1016\/j.disamonth.2025.101853_bib0263","doi-asserted-by":"crossref","first-page":"112","DOI":"10.2174\/1871527311312010017","article-title":"Opioid withdrawal syndrome: emerging concepts and novel therapeutic targets","volume":"12","author":"Rehni","year":"2013","journal-title":"CNS Neurol Disord Drug Targets"},{"issue":"7","key":"10.1016\/j.disamonth.2025.101853_bib0264","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1007\/s00213-023-06370-2","article-title":"Opioid withdrawal: role in addiction and neural mechanisms","volume":"240","author":"Monroe","year":"2023","journal-title":"Psychopharmacology (Berl)"},{"issue":"2","key":"10.1016\/j.disamonth.2025.101853_bib0265","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1080\/02791072.2003.10400007","article-title":"The clinical opiate withdrawal scale (COWS)","volume":"35","author":"Wesson","year":"2003","journal-title":"J Psychoactive Drugs"},{"key":"10.1016\/j.disamonth.2025.101853_bib0266","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.drugalcdep.2015.03.036","article-title":"Examining the factor structure of the Clinical Opiate Withdrawal Scale: a secondary data analysis from the National Drug Abuse Treatment Clinical Trials Network (CTN) 0003","volume":"152","author":"Barbosa-Leiker","year":"2015","journal-title":"Drug Alcohol Depend"},{"issue":"1","key":"10.1016\/j.disamonth.2025.101853_bib0267","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1080\/10550887.2022.2131957","article-title":"Repeated measures analysis of opioid use disorder treatment on clinical opiate withdrawal scale in a randomized clinical trial: sex differences","volume":"42","author":"Wang","year":"2024","journal-title":"J Addict Dis"},{"issue":"9","key":"10.1016\/j.disamonth.2025.101853_bib0268","doi-asserted-by":"crossref","first-page":"2540","DOI":"10.1111\/add.15818","article-title":"Cunningham CO. Clinical management of opioid withdrawal","volume":"117","author":"Torres-Lockhart","year":"2022","journal-title":"Addiction"},{"issue":"7","key":"10.1016\/j.disamonth.2025.101853_bib0269","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/S2215-0366(24)00068-3","article-title":"Establishing a research agenda for the study and assessment of opioid withdrawal","volume":"11","author":"Dunn","year":"2024","journal-title":"Lanc Psych"},{"issue":"7","key":"10.1016\/j.disamonth.2025.101853_bib0270","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1111\/j.1553-2712.1996.tb03487.x","article-title":"Out-of-hospital treatment of opioid overdoses in an urban setting","volume":"3","author":"Sporer","year":"1996","journal-title":"Acad Emerg Med"},{"key":"10.1016\/j.disamonth.2025.101853_bib0271","doi-asserted-by":"crossref","DOI":"10.12659\/AJCR.929412","article-title":"Naloxone-induced acute pulmonary edema is dose-dependent: a case series","volume":"22","author":"Al-Azzawi","year":"2021","journal-title":"Am J Case Rep"},{"issue":"1","key":"10.1016\/j.disamonth.2025.101853_bib0272","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1080\/15563650.2016.1209767","article-title":"A case of U-47700 overdose with laboratory confirmation and metabolite identification","volume":"55","author":"Jones","year":"2017","journal-title":"Clin Toxicol (Phila)"},{"issue":"2","key":"10.1016\/j.disamonth.2025.101853_bib0273","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s00101-012-1982-8","article-title":"Fallbericht mit Literatur\u00fcbersicht und kritischer Bewertung [Naloxone-induced pulmonary edema. Case report with review of the literature and critical evaluation]","volume":"61","author":"Lassen","year":"2012","journal-title":"Anaesthesist"},{"issue":"5","key":"10.1016\/j.disamonth.2025.101853_bib0274","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1080\/15563650.2024.2348108","article-title":"Pulmonary edema after naloxone administration for opioid reversal: a systematic review of case reports and causality assessment using the Naranjo scale","volume":"62","author":"Joseph","year":"2024","journal-title":"Clin Toxicol (Phila)"},{"issue":"3","key":"10.1016\/j.disamonth.2025.101853_bib0275","doi-asserted-by":"crossref","first-page":"e12740","DOI":"10.1002\/emp2.12740","article-title":"Naloxone-associated pulmonary edema in a 3-year-old with opioid overdose","volume":"3","author":"Grout","year":"2022","journal-title":"J Am Coll Emerg Physicians Open"},{"key":"10.1016\/j.disamonth.2025.101853_bib0276","doi-asserted-by":"crossref","DOI":"10.4178\/epih.e2017050","article-title":"Clinical and laboratory findings of rhabdomyolysis in opioid overdose patients in the intensive care unit of a poisoning center in 2014 in Iran","volume":"39","author":"Babak","year":"2017","journal-title":"Epidemiol Health"},{"issue":"5","key":"10.1016\/j.disamonth.2025.101853_bib0277","doi-asserted-by":"crossref","first-page":"2440","DOI":"10.1111\/hex.13559","article-title":"Design details for overdose education and take-home naloxone kits: codesign with family medicine, emergency department, addictions medicine and community","volume":"25","author":"Sellen","year":"2022","journal-title":"Health Expect"},{"issue":"7","key":"10.1016\/j.disamonth.2025.101853_bib0278","doi-asserted-by":"crossref","first-page":"E534","DOI":"10.1001\/amajethics.2024.534","article-title":"How should harm reduction strategies differ for adolescents and adults?","volume":"26","author":"Heward","year":"2024","journal-title":"AMA J Ethics"},{"issue":"7","key":"10.1016\/j.disamonth.2025.101853_bib0279","doi-asserted-by":"crossref","first-page":"E572","DOI":"10.1001\/amajethics.2024.572","article-title":"What would equitable harm reduction look like?","volume":"26","author":"Jegede","year":"2024","journal-title":"AMA J Ethics"},{"issue":"2","key":"10.1016\/j.disamonth.2025.101853_bib0280","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1111\/jep.13941","article-title":"Clinical harm reduction in substance use: an ethics-oriented primer and critique for hospital-based providers","volume":"30","author":"Kontos","year":"2024","journal-title":"J Eval Clin Pract"},{"issue":"1","key":"10.1016\/j.disamonth.2025.101853_bib0281","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1186\/s12954-024-01076-w","article-title":"A qualitative exploration of harm reduction in practice by street-based peer outreach workers","volume":"21","author":"Owczarzak","year":"2024","journal-title":"Harm Reduct J"},{"issue":"1","key":"10.1016\/j.disamonth.2025.101853_bib0282","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1080\/15504263.2023.2295416","article-title":"A harm reduction framework for integrated treatment of co-occurring opioid use disorder and trauma-related disorders","volume":"20","author":"Israel","year":"2024","journal-title":"J Dual Diagn"},{"issue":"5","key":"10.1016\/j.disamonth.2025.101853_bib0283","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1097\/ADM.0000000000000223","article-title":"Prescribe to prevent: overdose prevention and naloxone rescue kits for prescribers and pharmacists","volume":"10","author":"Lim","year":"2016","journal-title":"J Addict Med"},{"key":"10.1016\/j.disamonth.2025.101853_bib0284","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.drugalcdep.2018.08.003","article-title":"Cost-effectiveness of naloxone kits in secondary schools","volume":"192","author":"Cipriano","year":"2018","journal-title":"Drug Alcohol Depend"},{"issue":"3","key":"10.1016\/j.disamonth.2025.101853_bib0285","doi-asserted-by":"crossref","first-page":"e210","DOI":"10.1016\/S2468-2667(21)00304-2","article-title":"Estimating naloxone need in the USA across fentanyl, heroin, and prescription opioid epidemics: a modelling study","volume":"7","author":"Irvine","year":"2022","journal-title":"Lanc Public Health"},{"issue":"4","key":"10.1016\/j.disamonth.2025.101853_bib0286","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1097\/ADM.0000000000001321","article-title":"Fentanyl test strips for harm reduction: a scoping review","volume":"18","author":"Kutscher","year":"2024","journal-title":"J Addict Med"},{"issue":"1","key":"10.1016\/j.disamonth.2025.101853_bib0287","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s12954-023-00921-8","article-title":"Testing the test strips: laboratory performance of fentanyl test strips","volume":"21","author":"Halifax","year":"2024","journal-title":"Harm Reduct J"},{"issue":"1","key":"10.1016\/j.disamonth.2025.101853_bib0288","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s12954-021-00478-4","article-title":"High concentrations of illicit stimulants and cutting agents cause false positives on fentanyl test strips","volume":"18","author":"Lockwood","year":"2021","journal-title":"Harm Reduct J"},{"key":"10.1016\/j.disamonth.2025.101853_bib0289","doi-asserted-by":"crossref","first-page":"4639","DOI":"10.2147\/RMHP.S244720","article-title":"Assessing drug consumption rooms and longer term (5 year) impacts on community and clients","volume":"14","author":"Tran","year":"2021","journal-title":"Risk Manag Healthc Policy"},{"issue":"5","key":"10.1016\/j.disamonth.2025.101853_bib0290","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1111\/j.1467-842X.1999.tb01306.x","article-title":"Establishing safe injecting rooms in Australia: attitudes of injecting drug users","volume":"23","author":"Fry","year":"1999","journal-title":"Aust N Z J Public Health"},{"issue":"8","key":"10.1016\/j.disamonth.2025.101853_bib0291","first-page":"759","article-title":"Potential use of safer injecting facilities among injection drug users in Vancouver's Downtown Eastside","volume":"169","author":"Kerr","year":"2003","journal-title":"CMAJ"},{"issue":"1","key":"10.1016\/j.disamonth.2025.101853_bib0292","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s12954-019-0319-1","article-title":"Prospective client survey and participatory process ahead of opening a mobile drug consumption room in Lisbon","volume":"16","author":"Taylor","year":"2019","journal-title":"Harm Reduct J"},{"key":"10.1016\/j.disamonth.2025.101853_bib0293","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.drugalcdep.2014.10.012","article-title":"Supervised injection services: what has been demonstrated? A systematic literature review","volume":"145","author":"Potier","year":"2014","journal-title":"Drug Alcohol Depend"},{"issue":"1","key":"10.1016\/j.disamonth.2025.101853_bib0294","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1186\/s12954-023-00887-7","article-title":"Willingness to use a drug consumption room among people who use drugs in Lyon, France, a city with no open scene of drug use (the TRABOUL survey)","volume":"20","author":"Chappuy","year":"2023","journal-title":"Harm Reduct J"},{"issue":"830","key":"10.1016\/j.disamonth.2025.101853_bib0295","first-page":"1127","article-title":"Drogues : mineur-e-s et r\u00e9duction des risques ? [Drugs: minors and harm reduction?]","volume":"19","author":"Armengaud","year":"2023","journal-title":"Rev Med Suisse"},{"issue":"8","key":"10.1016\/j.disamonth.2025.101853_bib0296","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1007\/s40263-016-0373-0","article-title":"Naltrexone: a pan-addiction treatment?","volume":"30","author":"Aboujaoude","year":"2016","journal-title":"CNS Drugs"},{"issue":"4","key":"10.1016\/j.disamonth.2025.101853_bib0297","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.psc.2004.06.002","article-title":"Pharmacologic management of relapse prevention in addictive disorders","volume":"27","author":"Sofuoglu","year":"2004","journal-title":"Psychiatr Clin North Am"},{"issue":"6","key":"10.1016\/j.disamonth.2025.101853_bib0298","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3928\/02793695-20240423-01","article-title":"The importance of nurse-patient relationships in the midst of substance misuse: support for rural youth well-being","volume":"62","author":"Preston","year":"2024","journal-title":"J Psychosoc Nurs Ment Health Serv"},{"key":"10.1016\/j.disamonth.2025.101853_bib0299","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1146\/annurev-publhealth-031914-122957","article-title":"The prescription opioid and heroin crisis: a public health approach to an epidemic of addiction","volume":"36","author":"Kolodny","year":"2015","journal-title":"Annu Rev Public Health"},{"issue":"6","key":"10.1016\/j.disamonth.2025.101853_bib0300","doi-asserted-by":"crossref","DOI":"10.1056\/EVIDra2200051","article-title":"Adolescent substance use disorders","volume":"1","author":"Simon","year":"2022","journal-title":"NEJM Evid"},{"key":"10.1016\/j.disamonth.2025.101853_bib0301","series-title":"Institute of Medicine (US) Committee on Federal Regulation of Methadone Treatment","first-page":"5","year":"1995"},{"key":"10.1016\/j.disamonth.2025.101853_bib0302","series-title":"StatPearls [Internet]","article-title":"Methadone","author":"Durrani","year":"2024"},{"issue":"2S Suppl 1","key":"10.1016\/j.disamonth.2025.101853_bib0303","first-page":"1","article-title":"The ASAM national practice guideline for the treatment of opioid use disorder: 2020 focused update","volume":"14","year":"2020","journal-title":"J Addict Med"},{"key":"10.1016\/j.disamonth.2025.101853_bib0304","series-title":"Behavioral Pediatrics III: Mental Health and Management","first-page":"229","article-title":"Substance use disorders in adolescents: pharmacologic management","author":"Greydanus","year":"2022"},{"issue":"2","key":"10.1016\/j.disamonth.2025.101853_bib0305","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0740-5472(02)00259-3","article-title":"History and current status of opioid maintenance treatments: blending conference session","author":"Kreek","year":"2002","journal-title":"J Subst Abuse Treat"},{"issue":"1","key":"10.1016\/j.disamonth.2025.101853_bib0306","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1056\/NEJMp1802741","article-title":"Primary care and the opioid-overdose crisis - buprenorphine myths and realities","volume":"379","author":"Wakeman","year":"2018","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.disamonth.2025.101853_bib0307","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1056\/NEJMp1803982","article-title":"Methadone in primary care - one small step for congress, one giant leap for addiction treatment","volume":"379","author":"Samet","year":"2018","journal-title":"N Engl J Med"},{"issue":"25","key":"10.1016\/j.disamonth.2025.101853_bib0308","doi-asserted-by":"crossref","first-page":"567","DOI":"10.15585\/mmwr.mm7325a1","article-title":"Treatment for opioid use disorder: population estimates - United States, 2022","volume":"73","author":"Dowell","year":"2024","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"1","key":"10.1016\/j.disamonth.2025.101853_bib0309","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.biopsych.2019.06.020","article-title":"Medication treatment of opioid use disorder","volume":"87","author":"Bell","year":"2020","journal-title":"Biol Psychiatry"},{"issue":"3","key":"10.1016\/j.disamonth.2025.101853_bib0310","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1111\/bcpt.13975","article-title":"Methadone pharmacokinetics in opioid agonist treatment: influencing factors and clinical implications","volume":"134","author":"Chalabianloo","year":"2024","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"10.1016\/j.disamonth.2025.101853_bib0311","doi-asserted-by":"crossref","DOI":"10.1136\/spcare-2023-004674","article-title":"Methadone as an adjuvant analgesic","author":"Shahab","year":"2024","journal-title":"BMJ Support Palliat Care"},{"key":"10.1016\/j.disamonth.2025.101853_bib0312","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2024.1467826","article-title":"Editorial: reviews in opioid use disorders","volume":"12","author":"Walwyn","year":"2024","journal-title":"Front Public Health"},{"issue":"2","key":"10.1016\/j.disamonth.2025.101853_bib0313","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s40265-024-02001-y","article-title":"Methadone for cancer pain management in children: a review of literature","volume":"84","author":"Mercadante","year":"2024","journal-title":"Drugs"},{"issue":"4","key":"10.1016\/j.disamonth.2025.101853_bib0314","doi-asserted-by":"crossref","first-page":"e43","DOI":"10.1213\/ANE.0000000000007158","article-title":"Intraoperative methadone: safe for widespread use?","volume":"139","author":"Weingarten","year":"2024","journal-title":"Anesth Analg"},{"issue":"9","key":"10.1016\/j.disamonth.2025.101853_bib0315","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.5498\/wjp.v14.i9.1285","article-title":"Personalized medicine and opioid use disorder","volume":"14","author":"Kaya-Aky\u00fczl\u00fc","year":"2024","journal-title":"World J Psychiatry"},{"key":"10.1016\/j.disamonth.2025.101853_bib0316","doi-asserted-by":"crossref","DOI":"10.1111\/dar.13890","article-title":"Assessment of treatment retention rates and predictors of retention on opioid agonist treatment among adolescents","author":"Shakya","year":"2024","journal-title":"Drug Alcohol Rev"},{"issue":"2","key":"10.1016\/j.disamonth.2025.101853_bib0317","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.jadohealth.2023.08.047","article-title":"Medications for opioid use disorder for youth: patient, caregiver, and clinician perspectives","volume":"74","author":"Buchholz","year":"2024","journal-title":"J Adolesc Health"},{"key":"10.1016\/j.disamonth.2025.101853_bib0318","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2024.111251","article-title":"Unmet need for medication for opioid use disorder among persons who inject drugs in 23\u2009U.S. cities","volume":"257","author":"Handanagic","year":"2024","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.disamonth.2025.101853_bib0319","article-title":"Methadone take-home policies and associated mortality: permitting versus non-permitting states","volume":"18","author":"Harris","year":"2024","journal-title":"Subst Use"},{"issue":"4","key":"10.1016\/j.disamonth.2025.101853_bib0320","doi-asserted-by":"crossref","first-page":"393","DOI":"10.15288\/jsad.2019.80.393","article-title":"Medications for maintenance treatment of opioid use disorder in adolescents: a narrative review and assessment of clinical benefits and potential risks","volume":"80","author":"Camenga","year":"2019","journal-title":"J Stud Alcohol Drugs"},{"issue":"5","key":"10.1016\/j.disamonth.2025.101853_bib0321","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2020-240647","article-title":"Interaction between methadone and clarithromycin as the suspected cause of an opioid toxidrome","volume":"14","author":"Wallace","year":"2021","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.disamonth.2025.101853_bib0322","doi-asserted-by":"crossref","DOI":"10.1037\/ort0000795","article-title":"What are the reasons for injected methadone use? A qualitative study of people who use drugs parenterally in Barcelona","author":"Tineo","year":"2024","journal-title":"Am J Orthopsychiatry"},{"issue":"3","key":"10.1016\/j.disamonth.2025.101853_bib0323","doi-asserted-by":"crossref","first-page":"37517","DOI":"10.52965\/001c.37517","article-title":"Buprenorphine and its formulations: a comprehensive review","volume":"10","author":"Poliwoda","year":"2022","journal-title":"Health Psychol Res"},{"issue":"1","key":"10.1016\/j.disamonth.2025.101853_bib0324","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s40122-019-00143-6","article-title":"A narrative pharmacological review of buprenorphine: a unique opioid for the treatment of chronic pain","volume":"9","author":"Gudin","year":"2020","journal-title":"Pain Ther"},{"issue":"5","key":"10.1016\/j.disamonth.2025.101853_bib0325","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1248\/bpb.25.682","article-title":"Inhibition of human drug metabolizing cytochrome P450 by buprenorphine","volume":"25","author":"Umehara","year":"2002","journal-title":"Biol Pharm Bull"},{"issue":"7","key":"10.1016\/j.disamonth.2025.101853_bib0326","doi-asserted-by":"crossref","DOI":"10.1001\/jamahealthforum.2023.1982","article-title":"Characteristics and prescribing patterns of clinicians waivered to prescribe buprenorphine for opioid use disorder before and after release of new practice guidelines","volume":"4","author":"Jones","year":"2023","journal-title":"JAMA Health Forum"},{"key":"10.1016\/j.disamonth.2025.101853_bib0327","article-title":"State alignment with federal regulations in 2022 to relax buprenorphine 30-patient waiver requirements","volume":"7","author":"Silwal","year":"2023","journal-title":"Drug Alcohol Depend Rep"},{"issue":"5","key":"10.1016\/j.disamonth.2025.101853_bib0328","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.12419","article-title":"Survey of barriers and facilitators to prescribing buprenorphine and clinician perceptions on the Drug Addiction Treatment Act of 2000 waiver","volume":"5","author":"Lanham","year":"2022","journal-title":"JAMA Netw Open"},{"issue":"22","key":"10.1016\/j.disamonth.2025.101853_bib0329","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1056\/NEJMp1508818","article-title":"Preventing and treating narcotic addiction\u2013Century of federal drug control","volume":"373","author":"Courtwright","year":"2015","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.disamonth.2025.101853_bib0330","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1176\/ajp.136.6.782","article-title":"Research and development of naltrexone: a new narcotic antagonist","volume":"136","author":"Julius","year":"1979","journal-title":"Am J Psychiatry"},{"issue":"8 Pt 1","key":"10.1016\/j.disamonth.2025.101853_bib0331","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.2105\/AJPH.85.8_Pt_1.1157","article-title":"The rise of the modern addict","volume":"85","author":"Jonnes","year":"1995","journal-title":"Am J Public Health"},{"issue":"2","key":"10.1016\/j.disamonth.2025.101853_bib0332","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1080\/02791072.1995.10471683","article-title":"The demedicalization of methadone maintenance","volume":"27","author":"Rosenbaum","year":"1995","journal-title":"J Psychoactive Drugs"},{"issue":"3","key":"10.1016\/j.disamonth.2025.101853_bib0333","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1111\/j.1542-2011.2011.00062.x","article-title":"Governmental oversight of prescribing medications: history of the US Food and Drug Administration and prescriptive authority","volume":"56","author":"Plank","year":"2011","journal-title":"J Midwifery Womens Health"},{"issue":"3","key":"10.1016\/j.disamonth.2025.101853_bib0334","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1056\/NEJMp1206652","article-title":"Two centuries of assessing drug risks","volume":"367","author":"Avorn","year":"2012","journal-title":"N Engl J Med"},{"issue":"1\u20132","key":"10.1016\/j.disamonth.2025.101853_bib0335","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1080\/1536710X.2013.870515","article-title":"The Affordable Care Act and integrated care","volume":"13","author":"Kuramoto","year":"2014","journal-title":"J Soc Work Disabil Rehabil"},{"issue":"3","key":"10.1016\/j.disamonth.2025.101853_bib0336","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1080\/15360288.2016.1211213","article-title":"Evaluation of US Federal legislation for opioid abuse: 1973-2016","volume":"30","author":"Ruble","year":"2016","journal-title":"J Pain Palliat Care Pharmacother"},{"issue":"5","key":"10.1016\/j.disamonth.2025.101853_bib0337","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1213\/ANE.0000000000002403","article-title":"The US opioid crisis: current federal and state legal issues","volume":"125","author":"Soelberg","year":"2017","journal-title":"Anesth Analg"},{"key":"10.1016\/j.disamonth.2025.101853_bib0338","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jsat.2018.11.005","article-title":"Interpretation and integration of the federal substance use privacy protection rule in integrated health systems: a qualitative analysis","volume":"97","author":"Campbell","year":"2019","journal-title":"J Subst Abuse Treat"},{"issue":"1","key":"10.1016\/j.disamonth.2025.101853_bib0339","first-page":"1","article-title":"A History of United States cannabis law","volume":"34","author":"Patton","year":"2020","journal-title":"J Law Health"},{"issue":"1","key":"10.1016\/j.disamonth.2025.101853_bib0340","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1089\/jpm.2021.0478","article-title":"De-stigmatizing the language of addiction #429","volume":"25","author":"Ho","year":"2022","journal-title":"J Palliat Med"},{"issue":"18","key":"10.1016\/j.disamonth.2025.101853_bib0341","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1001\/jama.2012.14282","article-title":"Rethinking opioid prescribing to protect patient safety and public health","volume":"308","author":"Alexander","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.disamonth.2025.101853_bib0342","article-title":"Buprenorphine implants (Probuphine) for opioid dependence","volume":"58","year":"2016"},{"issue":"1541","key":"10.1016\/j.disamonth.2025.101853_bib0343","first-page":"35","article-title":"Once-monthly subcutaneous buprenorphine (Sublocade) for opioid use disorder","volume":"60","year":"2018","journal-title":"Med Lett Drugs Ther"},{"issue":"1","key":"10.1016\/j.disamonth.2025.101853_bib0344","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1186\/s13256-024-04483-6","article-title":"Patients' perspectives on buprenorphine subcutaneous implant: a case series","volume":"18","author":"Pierlorenzi","year":"2024","journal-title":"J Med Case Rep"},{"issue":"1","key":"10.1016\/j.disamonth.2025.101853_bib0345","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s13722-024-00479-1","article-title":"Rapid induction of transdermal buprenorphine to subcutaneous extended-release buprenorphine for the treatment of opioid use disorder","volume":"19","author":"Azar","year":"2024","journal-title":"Addict Sci Clin Pract"},{"issue":"5","key":"10.1016\/j.disamonth.2025.101853_bib0346","first-page":"313","article-title":"Buprenorphine therapy for opioid use disorder","volume":"97","author":"Zoorob","year":"2018","journal-title":"Am Fam Physician"},{"key":"10.1016\/j.disamonth.2025.101853_bib0347","series-title":"StatPearls [Internet]","article-title":"Buprenorphine. 2024 Jun 8","author":"Kumar","year":"2024"},{"key":"10.1016\/j.disamonth.2025.101853_bib0348","series-title":"StatPearls [Internet]","article-title":"Opioid use disorder. 2024 Jan 17","author":"Dydyk","year":"2024"},{"issue":"4","key":"10.1016\/j.disamonth.2025.101853_bib0349","doi-asserted-by":"crossref","first-page":"B9","DOI":"10.5055\/bupe.24.rpj.1040","article-title":"The opioid that cried 'partial agonist","volume":"20","author":"Bettinger","year":"2024","journal-title":"J Opioid Manag"},{"issue":"10","key":"10.1016\/j.disamonth.2025.101853_bib0350","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1001\/jamainternmed.2024.3977","article-title":"Buprenorphine for opioid use disorder-an essential medical treatment","volume":"184","author":"Weimer","year":"2024","journal-title":"JAMA Intern Med"},{"issue":"3","key":"10.1016\/j.disamonth.2025.101853_bib0351","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.amjmed.2023.11.004","article-title":"Buprenorphine use in the United States, 2010-2019","volume":"137","author":"Thompson","year":"2024","journal-title":"Am J Med"},{"issue":"4","key":"10.1016\/j.disamonth.2025.101853_bib0352","doi-asserted-by":"crossref","first-page":"B1","DOI":"10.5055\/bupe.24.rpj.1035","article-title":"Buprenorphine: not just another opioid - understanding the world's most interesting opioid","volume":"20","author":"Rubinstein","year":"2024","journal-title":"J Opioid Manag"},{"issue":"7","key":"10.1016\/j.disamonth.2025.101853_bib0353","article-title":"Extended-release 7-day injectable buprenorphine for patients with minimal to mild opioid withdrawal","volume":"7","author":"D'Onofrio","year":"2024","journal-title":"JAMA Netw Open"},{"issue":"4","key":"10.1016\/j.disamonth.2025.101853_bib0354","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1055\/s-0044-1787569","article-title":"Availability and opportunities for expansion of buprenorphine for the treatment of opioid use disorder","volume":"44","author":"McKendrick","year":"2024","journal-title":"Semin Neurol"},{"issue":"1","key":"10.1016\/j.disamonth.2025.101853_bib0355","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jadohealth.2024.04.010","article-title":"Injectable buprenorphine: an opportunity to improve treatment access for youth with opioid use disorder","volume":"75","author":"Calihan","year":"2024","journal-title":"J Adolesc Health"},{"key":"10.1016\/j.disamonth.2025.101853_bib0356","first-page":"1","article-title":"Buprenorphine: two adolescent case reports of bridging the transmucosal form to the extended-release subcutaneous injectable form","author":"Velagapudi","year":"2024","journal-title":"J Addict Dis"},{"issue":"8","key":"10.1016\/j.disamonth.2025.101853_bib0357","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1001\/jamapediatrics.2017.0745","article-title":"Trends in receipt of buprenorphine and naltrexone for opioid use disorder among adolescents and young adults, 2001-2014","volume":"171","author":"Hadland","year":"2017","journal-title":"JAMA Pediatr"},{"issue":"8","key":"10.1016\/j.disamonth.2025.101853_bib0358","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0297567","article-title":"Lost in transition: a protocol for a retrospective, longitudinal cohort study for addressing challenges in opioid treatment for transition-age adults","volume":"19","author":"Aleksanyan","year":"2024","journal-title":"PLoS ONE"},{"key":"10.1016\/j.disamonth.2025.101853_bib0359","article-title":"Patient and provider medication preferences affect treatment outcomes among adolescents and young adults with opioid use disorder","volume":"162","author":"Monico","year":"2024","journal-title":"J Subst Use Addict Treat"},{"issue":"4","key":"10.1016\/j.disamonth.2025.101853_bib0360","first-page":"765","article-title":"Buprenorphine enhanced taper tolerability evaluation report (BETTER): a case series","volume":"45","author":"Epland","year":"2024","journal-title":"Subst Use Addctn J."},{"issue":"1","key":"10.1016\/j.disamonth.2025.101853_bib0361","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.jadohealth.2024.01.012","article-title":"Early remission of opioid use disorder in an adolescent using buprenorphine extended - release subcutaneous injection: a case report","volume":"75","author":"Schmuhl","year":"2024","journal-title":"J Adolesc Health"},{"issue":"5","key":"10.1016\/j.disamonth.2025.101853_bib0362","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1097\/ADM.0000000000001320","article-title":"Provider perceptions toward extended-release buprenorphine for treatment of opioid use disorder","volume":"18","author":"Reddy","year":"2024","journal-title":"J Addict Med"},{"issue":"9","key":"10.1016\/j.disamonth.2025.101853_bib0363","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.29583","article-title":"Economic evaluation of extended-release buprenorphine for persons with opioid use disorder","volume":"6","author":"Flam-Ross","year":"2023","journal-title":"JAMA Netw Open"},{"issue":"6","key":"10.1016\/j.disamonth.2025.101853_bib0364","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.17377","article-title":"Extended-release injection vs sublingual buprenorphine for opioid use disorder with fentanyl use: a post hoc analysis of a randomized clinical trial","volume":"7","author":"Nunes","year":"2024","journal-title":"JAMA Netw Open"},{"issue":"6","key":"10.1016\/j.disamonth.2025.101853_bib0365","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/S2215-0366(23)00095-0","article-title":"Buprenorphine versus methadone for the treatment of opioid dependence: a systematic review and meta-analysis of randomised and observational studies","volume":"10","author":"Degenhardt","year":"2023","journal-title":"Lanc Psychiatry"},{"issue":"17","key":"10.1016\/j.disamonth.2025.101853_bib0366","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1001\/jama.2008.574","article-title":"Extended vs short-term buprenorphine-naloxone for treatment of opioid-addicted youth: a randomized trial","volume":"300","author":"Woody","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/j.disamonth.2025.101853_bib0367","unstructured":"Buprenorphine\/naloxone Versus Methadone For the Treatment of Opioid dependence: A review of Comparative Clinical effectiveness, Cost-Effectiveness and Guidelines [Internet]. Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2016 Sep 2."},{"key":"10.1016\/j.disamonth.2025.101853_bib0368","series-title":"StatPearls [Internet]","article-title":"Buprenorphine and Naloxone. 2024 Feb 24","author":"Togioka","year":"2024"},{"issue":"10","key":"10.1016\/j.disamonth.2025.101853_bib0369","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1001\/jama.2024.11501","article-title":"Comparative safety of in utero exposure to buprenorphine combined with naloxone vs buprenorphine alone","volume":"332","author":"Straub","year":"2024","journal-title":"JAMA"},{"issue":"22","key":"10.1016\/j.disamonth.2025.101853_bib0370","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1056\/NEJMoa2203318","article-title":"Buprenorphine versus methadone for opioid use disorder in pregnancy","volume":"387","author":"Suarez","year":"2022","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.disamonth.2025.101853_bib0371","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1097\/GCO.0000000000000932","article-title":"Pharmacotherapy for opioid use disorder in pregnancy","volume":"36","author":"Trammel","year":"2024","journal-title":"Curr Opin Obstet Gynecol"},{"issue":"7","key":"10.1016\/j.disamonth.2025.101853_bib0372","first-page":"555","article-title":"Buprenorphine treatment may be safer than methadone during pregnancy","volume":"331","author":"Harris","year":"2024","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.disamonth.2025.101853_bib0373","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1080\/00952990.2016.1194851","article-title":"Emergency department visits by pediatric patients for poisoning by prescription opioids","volume":"42","author":"Tadros","year":"2016","journal-title":"Am J Drug Alcohol Abuse"},{"issue":"2","key":"10.1016\/j.disamonth.2025.101853_bib0374","doi-asserted-by":"crossref","first-page":"261","DOI":"10.2174\/1574886318666230731151447","article-title":"Dental disorders reported to the FDA Adverse Event Reporting System in association with buprenorphine: an analysis by ingredient composition and route of administration","volume":"19","author":"Woods","year":"2024","journal-title":"Curr Drug Saf"},{"issue":"7","key":"10.1016\/j.disamonth.2025.101853_bib0375","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajem.2008.01.039","article-title":"Serotonin syndrome triggered by a single dose of suboxone","volume":"26","author":"Isenberg","year":"2008","journal-title":"Am J Emerg Med"},{"key":"10.1016\/j.disamonth.2025.101853_bib0376","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2023.111032","article-title":"Characteristics, treatment patterns and retention with extended-release subcutaneous buprenorphine for opioid use disorder: a population-based cohort study in Ontario, Canada","volume":"254","author":"Iacono","year":"2024","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.disamonth.2025.101853_bib0377","article-title":"Buprenorphine, norbuprenorphine, and naloxone levels in adulterated urine samples: can they be detected when buprenorphine\/naloxone film is dipped into urine or water?","volume":"18","author":"Furo","year":"2024","journal-title":"Subst Use"},{"issue":"9","key":"10.1016\/j.disamonth.2025.101853_bib0378","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1080\/10826084.2023.2275559","article-title":"Investigation of simulated adherence in long-term buprenorphine\/naloxone treatment patients","volume":"59","author":"Rahman","year":"2024","journal-title":"Subst Use Misuse"},{"issue":"7","key":"10.1016\/j.disamonth.2025.101853_bib0379","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1111\/add.14180","article-title":"Extended-release injectable naltrexone for opioid use disorder: a systematic review","volume":"113","author":"Jarvis","year":"2018","journal-title":"Addiction"},{"issue":"5","key":"10.1016\/j.disamonth.2025.101853_bib0380","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1111\/ajad.13455","article-title":"Medication treatment for alcohol use disorder in special populations","author":"Malhotra","year":"2023","journal-title":"Am J Addict"},{"issue":"5","key":"10.1016\/j.disamonth.2025.101853_bib0381","first-page":"151","article-title":"Naltrexone and liver disease","author":"McDonough","year":"2015","journal-title":"Aust Prescr"},{"issue":"12","key":"10.1016\/j.disamonth.2025.101853_bib0382","doi-asserted-by":"crossref","first-page":"3433","DOI":"10.1002\/hep4.2080","article-title":"Naltrexone for alcohol use disorder: hepatic safety in patients with and without liver disease","volume":"6","author":"Ayyala","year":"2022","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.disamonth.2025.101853_bib0383","article-title":"LiverTox: clinical and research information on drug-induced liver injury [Internet]. Bethesda (MD): national Institute of Diabetes and Digestive and Kidney Diseases; 2012\u2013","year":"2020","journal-title":"Naltrexone"},{"issue":"11","key":"10.1016\/j.disamonth.2025.101853_bib0384","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1111\/add.16630","article-title":"Comparative effectiveness of extended-release naltrexone and sublingual buprenorphine for treatment of opioid use disorder among Medicaid patients","volume":"119","author":"Ross","year":"2024","journal-title":"Addiction"},{"key":"10.1016\/j.disamonth.2025.101853_bib0385","article-title":"Adverse events at 1\u2009month following medication initiation for opioid use disorder among adolescents and young adults","author":"Terplan","year":"2024","journal-title":"Subst Use Addctn J"},{"key":"10.1016\/j.disamonth.2025.101853_bib0386","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsat.2021.108407","article-title":"Extended-release naltrexone for youth with opioid use disorder","volume":"130","author":"Mitchell","year":"2021","journal-title":"J Subst Abuse Treat"},{"key":"10.1016\/j.disamonth.2025.101853_bib0387","doi-asserted-by":"crossref","DOI":"10.1097\/ADM.0000000000001342","article-title":"Diagnosis and treatment of presumed naltrexone-XR-precipitated opioid withdrawal in a patient chronically treated with buprenorphine-XR: a case report","author":"Moore","year":"2024","journal-title":"J Addict Med"},{"key":"10.1016\/j.disamonth.2025.101853_bib0388","series-title":"Substance Abuse in Adolescents and Young Adults: A Manual For Pediatric and Primary Care Clinicians","first-page":"261","article-title":"Substance use disorders in adolescents: pharmacologic management","author":"Greydanus","year":"2017"},{"issue":"8","key":"10.1016\/j.disamonth.2025.101853_bib0389","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1001\/archpsyc.55.8.729","article-title":"Induction with levomethadyl acetate: safety and efficacy","volume":"55","author":"Jones","year":"1998","journal-title":"Arch Gen Psychiatry"},{"issue":"8","key":"10.1016\/j.disamonth.2025.101853_bib0390","first-page":"39","article-title":"Rx: 3x\/week LAAM: alternative to methadone. Clinical studies: phase I","author":"Sollod","year":"1976","journal-title":"NIDA Res Monogr"},{"issue":"4","key":"10.1016\/j.disamonth.2025.101853_bib0391","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1136\/ebmh.5.4.107","article-title":"Review: levomethadyl acetate hydrochloride improves retention in treatment and reduces heroin use in heroin dependence","volume":"5","author":"Law","year":"2002","journal-title":"Evid Based Ment Health"},{"issue":"22","key":"10.1016\/j.disamonth.2025.101853_bib0392","doi-asserted-by":"crossref","first-page":"2469","DOI":"10.1001\/archinte.167.22.2469","article-title":"QT-interval effects of methadone, levomethadyl, and buprenorphine in a randomized trial","volume":"167","author":"Wedam","year":"2007","journal-title":"Arch Intern Med"},{"issue":"4","key":"10.1016\/j.disamonth.2025.101853_bib0393","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1300\/J069v20n04_02","article-title":"Torsades de pointes associated with high dose levomethadyl acetate (ORLAAM)","volume":"20","author":"Deamer","year":"2001","journal-title":"J Addict Dis"},{"issue":"10","key":"10.1016\/j.disamonth.2025.101853_bib0394","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1177\/0091270011422816","article-title":"Opioids, QTc prolongation, and torsades","volume":"52","author":"Kurt","year":"2012","journal-title":"J Clin Pharmacol"},{"issue":"1","key":"10.1016\/j.disamonth.2025.101853_bib0395","doi-asserted-by":"crossref","first-page":"27","DOI":"10.2174\/1573403X1201160126122405","article-title":"The impact of opioids on cardiac electrophysiology","volume":"12","author":"Wedam","year":"2016","journal-title":"Curr Cardiol Rev"},{"issue":"5","key":"10.1016\/j.disamonth.2025.101853_bib0396","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.tcm.2023.03.006","article-title":"Opioids-induced inhibition of HERG ion channels and sudden cardiac death, a systematic review of current literature","author":"El Sherbini","year":"2024","journal-title":"Trends Cardiovasc Med"},{"issue":"21","key":"10.1016\/j.disamonth.2025.101853_bib0397","doi-asserted-by":"crossref","first-page":"2705","DOI":"10.1001\/jama.285.21.2705-JFD10005-3-1","article-title":"Labeling changes for Orlaam","volume":"285","author":"Schwetz","year":"2001","journal-title":"JAMA"},{"issue":"9","key":"10.1016\/j.disamonth.2025.101853_bib0398","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1111\/j.1360-0443.2007.01976.x","article-title":"Can LAAM, like Lazarus, come back from the dead?","volume":"102","author":"Jaffe","year":"2007","journal-title":"Addiction"},{"issue":"8","key":"10.1016\/j.disamonth.2025.101853_bib0399","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1111\/j.1360-0443.2005.01122.x","article-title":"Levo-alpha-acetylmethadol (LAAM) versus methadone: treatment retention and opiate use","volume":"100","author":"Longshore","year":"2005","journal-title":"Addiction"},{"issue":"1","key":"10.1016\/j.disamonth.2025.101853_bib0400","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1055\/s-0028-1083818","article-title":"A randomized, open-label trial comparing methadone and Levo-Alpha-Acetylmethadol (LAAM) in maintenance treatment of opioid addiction","volume":"42","author":"Wolstein","year":"2009","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.disamonth.2025.101853_bib0401","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.jconrel.2024.06.071","article-title":"Nor-LAAM loaded PLGA microparticles for treating opioid use disorder","volume":"373","author":"Ingabire","year":"2024","journal-title":"J Control Release"},{"key":"10.1016\/j.disamonth.2025.101853_bib0402","series-title":"StatPearls [Internet]","article-title":"Clonidine","author":"Yasaei","year":"2023"},{"key":"10.1016\/j.disamonth.2025.101853_bib0403","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/164_2024_714","article-title":"Presynaptic adrenoceptors","volume":"285","author":"Szabo","year":"2024","journal-title":"Handb Exp Pharmacol"},{"key":"10.1016\/j.disamonth.2025.101853_bib0404","series-title":"[Internet]","year":"2024"},{"issue":"3","key":"10.1016\/j.disamonth.2025.101853_bib0405","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.36922\/itps.1918","article-title":"A historical perspective on clonidine as an alpha-2A receptor agonist in the treatment of addictive behaviors: focus on opioid dependence","volume":"7","author":"Gold","year":"2024","journal-title":"INNOSC Theran Pharmacol Sci"},{"issue":"4","key":"10.1016\/j.disamonth.2025.101853_bib0406","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1111\/bcpt.13979","article-title":"Review of clinical pharmacokinetics and pharmacodynamics of clonidine as an adjunct to opioids in palliative care","volume":"134","author":"Amna","year":"2024","journal-title":"Basic Clin Pharmacol Toxicol"},{"issue":"4","key":"10.1016\/j.disamonth.2025.101853_bib0407","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1080\/02791072.2021.1908644","article-title":"Case report: concurrent clonidine abuse and opioid use disorder","volume":"53","author":"Mitchell","year":"2021","journal-title":"J Psychoactive Drugs"},{"issue":"13","key":"10.1016\/j.disamonth.2025.101853_bib0408","first-page":"927","article-title":"FDA approves nonopioid medication for managing opioid withdrawal","volume":"75","author":"Traynor","year":"2018","journal-title":"Am J Health Syst Pharm"},{"issue":"1","key":"10.1016\/j.disamonth.2025.101853_bib0409","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s40122-018-0108-7","article-title":"The role of lofexidine in management of opioid withdrawal","author":"Pergolizzi","year":"2019","journal-title":"Pain Ther"},{"issue":"6","key":"10.1016\/j.disamonth.2025.101853_bib0410","first-page":"e4827","article-title":"Clinical efficacy and safety profile of lofexidine hydrochloride in treating opioid withdrawal symptoms: a review of literature","volume":"11","author":"Rehman","year":"2019","journal-title":"Cureus"},{"issue":"3","key":"10.1016\/j.disamonth.2025.101853_bib0411","first-page":"e56561","article-title":"A comprehensive review of novel FDA-approved psychiatric medications (2018-2022)","volume":"16","author":"Giliberto","year":"2024","journal-title":"Cureus"},{"issue":"5","key":"10.1016\/j.disamonth.2025.101853_bib0412","article-title":"Alpha\u2082-adrenergic agonists for the management of opioid withdrawal","author":"Gowing","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"issue":"10","key":"10.1016\/j.disamonth.2025.101853_bib0413","doi-asserted-by":"crossref","first-page":"413","DOI":"10.4140\/TCP.n.2020.413","article-title":"A novel treatment option for opioid withdrawal symptoms","volume":"35","author":"Hilas","year":"2020","journal-title":"Sr Care Pharm"},{"issue":"8","key":"10.1016\/j.disamonth.2025.101853_bib0414","first-page":"e27639","article-title":"Managing opioid withdrawal in an outpatient setting with lofexidine or clonidine","volume":"14","author":"Gripshover","year":"2022","journal-title":"Cureus"},{"issue":"1","key":"10.1016\/j.disamonth.2025.101853_bib0415","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s40429-020-00353-5","article-title":"Improving translational research outcomes for opioid use disorder treatments","volume":"8","author":"Jones","year":"2021","journal-title":"Curr Addict Rep"},{"issue":"3","key":"10.1016\/j.disamonth.2025.101853_bib0416","first-page":"76","article-title":"A comprehensive update of lofexidine for the management of opioid withdrawal symptoms","volume":"50","author":"Urits","year":"2020","journal-title":"Psychopharmacol Bull"},{"issue":"1","key":"10.1016\/j.disamonth.2025.101853_bib0417","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.japh.2019.10.004","article-title":"Lofexidine versus clonidine for mitigation of opioid withdrawal symptoms: a systematic review","volume":"60","author":"Kuszmaul","year":"2020","journal-title":"J Am Pharm Assoc (2003)"},{"issue":"3","key":"10.1016\/j.disamonth.2025.101853_bib0418","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1097\/ADM.0000000000000473","article-title":"Lofexidine for opioid withdrawal: small effects at an exorbitant price","volume":"13","author":"Juurlink","year":"2019","journal-title":"J Addict Med"},{"issue":"2","key":"10.1016\/j.disamonth.2025.101853_bib0419","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1177\/15291006231198193","article-title":"Stigma toward substance dependence: causes, consequences, and potential interventions","volume":"24","author":"Krendl","year":"2023","journal-title":"Psychol Sci Public Interest"},{"key":"10.1016\/j.disamonth.2025.101853_bib0420","article-title":"You're Not Supposed to be on it Forever\": medications to treat opioid use disorder (MOUD) related stigma among drug treatment providers and people who use opioids","volume":"16","author":"Dickson-Gomez","year":"2022","journal-title":"Subst Abuse"},{"key":"10.1016\/j.disamonth.2025.101853_bib0421","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2022.109503","article-title":"Addiction onset and offset characteristics and public stigma toward people with common substance dependencies: a large national survey experiment","volume":"237","author":"Krendl","year":"2022","journal-title":"Drug Alcohol Depend."},{"issue":"12","key":"10.1016\/j.disamonth.2025.101853_bib0422","article-title":"Heroin maintenance for chronic heroin-dependent individuals","volume":"2011","author":"Ferri","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"10.1016\/j.disamonth.2025.101853_bib0423","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s10979-008-9138-8","article-title":"Explaining the effectiveness of heroin-assisted treatment on crime reductions","volume":"33","author":"L\u00f6bmann","year":"2009","journal-title":"Law Hum Behav"},{"issue":"1","key":"10.1016\/j.disamonth.2025.101853_bib0424","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1038\/s41398-023-02406-5","article-title":"Heroin and its metabolites: relevance to heroin use disorder","volume":"13","author":"Milella","year":"2023","journal-title":"Transl Psychiatry"},{"key":"10.1016\/j.disamonth.2025.101853_bib0425","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1192\/bjp.bp.106.026112","article-title":"Heroin-assisted treatment for opioid dependence: randomised controlled trial","volume":"191","author":"Haasen","year":"2007","journal-title":"Br J Psychiatry"},{"issue":"8","key":"10.1016\/j.disamonth.2025.101853_bib0426","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1056\/NEJMoa0810635","article-title":"Diacetylmorphine versus methadone for the treatment of opioid addiction","volume":"361","author":"Oviedo-Joekes","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.disamonth.2025.101853_bib0427","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/02791072.2024.2338734","article-title":"Building capacity for injectable diacetylmorphine and hydromorphone for the treatment of opioid use disorder: identifying typical doses","author":"Magel","year":"2024","journal-title":"J Psychoactive Drugs"},{"issue":"809\u201310","key":"10.1016\/j.disamonth.2025.101853_bib0428","first-page":"12","article-title":"Addictions : ce qui a chang\u00e9 en 2022 [Addiction: what's new in 2022]","volume":"19","author":"Novet","year":"2023","journal-title":"Rev Med Suisse"},{"key":"10.1016\/j.disamonth.2025.101853_bib0429","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2023.104025","article-title":"More than just 'free heroin': caring whilst navigating constraint in the delivery of diamorphine assisted treatment","volume":"116","author":"Poulter","year":"2023","journal-title":"Int J Drug Policy"},{"issue":"1","key":"10.1016\/j.disamonth.2025.101853_bib0430","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s13722-023-00367-0","article-title":"Feasibility, safety, and acceptability of intranasal heroin-assisted treatment in Switzerland: protocol for a prospective multicentre observational cohort study","volume":"18","author":"Westenberg","year":"2023","journal-title":"Addict Sci Clin Pract"},{"issue":"1","key":"10.1016\/j.disamonth.2025.101853_bib0431","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1186\/s12913-023-09558-6","article-title":"Clients' experiences on North America's first take-home injectable opioid agonist treatment (iOAT) program: a qualitative study","volume":"23","author":"Oviedo-Joekes","year":"2023","journal-title":"BMC Health Serv Res"},{"key":"10.1016\/j.disamonth.2025.101853_bib0432","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2021.103548","article-title":"Experiences with take-home dosing in heroin-assisted treatment in Switzerland during the COVID-19 pandemic-Is an update of legal restrictions warranted?","volume":"101","author":"Meyer","year":"2022","journal-title":"Int J Drug Policy"},{"key":"10.1016\/j.disamonth.2025.101853_bib0433","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2022.103670","article-title":"The United Kingdom's first unsanctioned overdose prevention site; A proof-of-concept evaluation","volume":"104","author":"Shorter","year":"2022","journal-title":"Int J Drug Policy"},{"key":"10.1016\/j.disamonth.2025.101853_bib0434","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2021.108984","article-title":"The suitability of oral diacetylmorphine in treatment-refractory patients with heroin dependence: a scoping review","volume":"227","author":"F Martins","year":"2021","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.disamonth.2025.101853_bib0435","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/bs.alkal.2021.04.001","article-title":"Morphine alkaloids: history, biology, and synthesis","volume":"86","author":"Wicks","year":"2021","journal-title":"Alkaloids Chem Biol"},{"key":"10.1016\/j.disamonth.2025.101853_bib0436","first-page":"191","article-title":"Extended-release morphine sulfate in treatment of severe acute and chronic pain","volume":"3","author":"Balch","year":"2010","journal-title":"J Pain Res"},{"issue":"4","key":"10.1016\/j.disamonth.2025.101853_bib0437","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1007\/s00103-010-1030-2","article-title":"Zum Stand der Substitutionstherapie in Deutschland [Status quo of opioid agonist maintenance therapy in Germany]","volume":"53","author":"Fischer","year":"2010","journal-title":"Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz"},{"issue":"4077","key":"10.1016\/j.disamonth.2025.101853_bib0438","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1126\/science.179.4077.1011","article-title":"Opiate receptor: demonstration in nervous tissue","volume":"179","author":"Pert","year":"1973","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.disamonth.2025.101853_bib0439","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1517\/14740338.2013.841136","article-title":"Sequestered naltrexone in sustained release morphine or oxycodone - a way to inhibit illicit use?","volume":"13","author":"Raffa","year":"2014","journal-title":"Expert Opin Drug Saf"},{"issue":"4","key":"10.1016\/j.disamonth.2025.101853_bib0440","article-title":"Oral morphine for cancer pain","volume":"4","author":"Wiffen","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"issue":"6","key":"10.1016\/j.disamonth.2025.101853_bib0441","article-title":"Slow-release oral morphine as maintenance therapy for opioid dependence","author":"Ferri","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"10.1016\/j.disamonth.2025.101853_bib0442","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1097\/YIC.0000000000000418","article-title":"Does slow release oral morphine have impact on craving and impulsivity in heroin dependent individuals?","volume":"38","author":"Giustiniani","year":"2023","journal-title":"Int Clin Psychopharmacol"},{"issue":"38","key":"10.1016\/j.disamonth.2025.101853_bib0443","doi-asserted-by":"crossref","first-page":"E1280","DOI":"10.1503\/cmaj.241173","article-title":"Management of opioid use disorder: 2024 update to the national clinical practice guideline","volume":"196","author":"Yakovenko","year":"2024","journal-title":"CMAJ"},{"issue":"9","key":"10.1016\/j.disamonth.2025.101853_bib0444","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1007\/s00115-024-01691-9","article-title":"Aktuelle Herausforderungen in der Behandlung der Opioidabh\u00e4ngigkeit [Challenges in the treatment of opioid dependence]","volume":"95","author":"Heinz","year":"2024","journal-title":"Nervenarzt"},{"key":"10.1016\/j.disamonth.2025.101853_bib0445","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsat.2021.108350","article-title":"Substitution treatment for opioid dependence with slow-release oral morphine: retention rate, health status, and substance use after switching to morphine","volume":"127","author":"Lehmann","year":"2021","journal-title":"J Subst Abuse Treat"},{"issue":"4","key":"10.1016\/j.disamonth.2025.101853_bib0446","doi-asserted-by":"crossref","first-page":"e240","DOI":"10.1097\/ADM.0000000000001149","article-title":"Outpatient rapid titration of slow release oral morphine for the treatment of opioid use disorder in a Canadian setting: a case series","volume":"17","author":"Brooks","year":"2023","journal-title":"J Addict Med"},{"issue":"8","key":"10.1016\/j.disamonth.2025.101853_bib0447","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1176\/appi.ajp.2013.12060782","article-title":"DSM-5 criteria for substance use disorders: recommendations and rationale","volume":"170","author":"Hasin","year":"2013","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.disamonth.2025.101853_bib0448","series-title":"StatPearls [Internet]","article-title":"Responsible controlled substance and opioid prescribing","author":"Horn","year":"2023"},{"key":"10.1016\/j.disamonth.2025.101853_bib0449","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/7854_2016_470","article-title":"Injection of pharmaceuticals designed for oral use: harms experienced and effective harm reduction through filtration","volume":"34","author":"McLean","year":"2017","journal-title":"Curr Top Behav Neurosci"},{"issue":"2","key":"10.1016\/j.disamonth.2025.101853_bib0450","first-page":"108","article-title":"Der Einfluss von retardiertem Morphin auf die Drogensituation in Osterreich [Impact of slow-release oral morphine on drug abusing habits in Austria]","volume":"24","author":"Beer","year":"2010","journal-title":"Neuropsychiatr"},{"issue":"7","key":"10.1016\/j.disamonth.2025.101853_bib0451","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1111\/j.1360-0443.2005.01148.x","article-title":"Driving capacity of patients treated with methadone and slow-release oral morphine","volume":"100","author":"Giacomuzzi","year":"2005","journal-title":"Addiction"},{"issue":"1","key":"10.1016\/j.disamonth.2025.101853_bib0452","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.emc.2023.06.023","article-title":"Substance use disorder","volume":"42","author":"Swimmer","year":"2024","journal-title":"Emerg Med Clin North Am"},{"issue":"8","key":"10.1016\/j.disamonth.2025.101853_bib0453","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1111\/add.14599","article-title":"L; World Health Organization's World Mental Health Surveys collaborators. Cross-national patterns of substance use disorder treatment and associations with mental disorder comorbidity in the WHO World Mental Health Surveys","volume":"114","author":"Harris","year":"2019","journal-title":"Addiction"},{"issue":"4","key":"10.1016\/j.disamonth.2025.101853_bib0454","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1097\/YCO.0000000000000510","article-title":"Treatment of substance use disorders with co-occurring severe mental health disorders","volume":"32","author":"Murthy","year":"2019","journal-title":"Curr Opin Psychiatry"},{"issue":"2","key":"10.1016\/j.disamonth.2025.101853_bib0455","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1177\/07067437211006872","article-title":"Estimating the prevalence of mental and substance use disorders: a systematic approach to triangulating available data to inform health systems planning","volume":"67","author":"Vigo","year":"2022","journal-title":"Can J Psychiatry"},{"issue":"1","key":"10.1016\/j.disamonth.2025.101853_bib0456","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/(SICI)1099-176X(199803)1:1<1::AID-MHP6>3.0.CO;2-Q","article-title":"Mental disorder and substance abuse","volume":"6","author":"Moscarelli","year":"2003","journal-title":"J Ment Health Policy Econ"},{"issue":"Suppl 3","key":"10.1016\/j.disamonth.2025.101853_bib0457","first-page":"623","article-title":"Comorbidity of substance use and mental disorders","volume":"29","author":"Struzik","year":"2017","journal-title":"Psychiatr Danub"},{"key":"10.1016\/j.disamonth.2025.101853_bib0458","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.drugalcdep.2018.12.030","article-title":"Co-occurring substance use and mental disorders among adults with opioid use disorder","volume":"197","author":"Jones","year":"2019","journal-title":"Drug Alcohol Depend"},{"issue":"2","key":"10.1016\/j.disamonth.2025.101853_bib0459","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.3390\/ijerph20021275","article-title":"Prevalence of attention deficit hyperactivity disorder (ADHD) among substance use disorder (SUD) populations: meta-analysis","volume":"20","author":"Rohner","year":"2023","journal-title":"Int J Environ Res Public Health"},{"issue":"12","key":"10.1016\/j.disamonth.2025.101853_bib0460","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1177\/1087054716629217","article-title":"Persistence and subtype stability of ADHD among substance use disorder treatment seekers","volume":"23","author":"Kaye","year":"2019","journal-title":"J Atten Disord"},{"issue":"4","key":"10.1016\/j.disamonth.2025.101853_bib0461","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1080\/15504263.2017.1343965","article-title":"The comorbidity of psychiatric and substance use disorders among Hispanic adolescents","volume":"13","author":"Gattamorta","year":"2017","journal-title":"J Dual Diagn"},{"issue":"6","key":"10.1016\/j.disamonth.2025.101853_bib0462","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1037\/0022-006X.70.6.1224","article-title":"Community studies on adolescent substance use, abuse, or dependence and psychiatric comorbidity","volume":"70","author":"Armstrong","year":"2002","journal-title":"J Consult Clin Psychol"},{"key":"10.1016\/j.disamonth.2025.101853_bib0463","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1192\/bjp.182.6.509","article-title":"Psychiatric morbidity and substance use in young people aged 13-15 years: results from the child and adolescent survey of mental health","volume":"182","author":"Boys","year":"2003","journal-title":"Br J Psychiatry"},{"issue":"3","key":"10.1016\/j.disamonth.2025.101853_bib0464","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1001\/jamapediatrics.2023.6263","article-title":"Substance use, suicidal thoughts, and psychiatric comorbidities among high school students","volume":"178","author":"Tervo-Clemmens","year":"2024","journal-title":"JAMA Pediatr"},{"key":"10.1016\/j.disamonth.2025.101853_bib0465","doi-asserted-by":"crossref","DOI":"10.1016\/j.pnpbp.2022.110623","article-title":"Circadian functioning and quality of life in substance use disorder patients with and without comorbid schizophrenia","volume":"120","author":"Hashemzadeh","year":"2023","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.disamonth.2025.101853_bib0466","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2023.1356817","article-title":"Editorial: comorbidity in bipolar disorder and schizophrenia, volume III","volume":"14","author":"Martinotti","year":"2024","journal-title":"Front Psychiatry"},{"key":"10.1016\/j.disamonth.2025.101853_bib0467","article-title":"Editorial: adolescent substance use prevention and treatment is our wheelhouse","author":"Vidal","year":"2024","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.disamonth.2025.101853_bib0468","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.jad.2024.08.055","article-title":"Healthcare resource utilisation and suicidal ideation amongst adolescents in the US with posttraumatic stress disorder, major depressive disorder, and substance use disorders using electronic health records","volume":"365","author":"Chan","year":"2024","journal-title":"J Affect Disord"},{"key":"10.1016\/j.disamonth.2025.101853_bib0469","doi-asserted-by":"crossref","DOI":"10.1016\/j.psychres.2024.115980","article-title":"The role of recurrent trauma on post-traumatic stress disorder symptoms and substance use among trauma exposed youth","volume":"338","author":"Leri","year":"2024","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.disamonth.2025.101853_bib0470","article-title":"A systematic review and meta-analysis of psychosocial interventions for persons with comorbid anxiety and substance use disorders","volume":"165","author":"Nardi","year":"2024","journal-title":"J Subst Use Addict Treat"},{"issue":"3","key":"10.1016\/j.disamonth.2025.101853_bib0471","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1007\/s11920-012-0264-0","article-title":"Exploring the comorbidity of anxiety and substance use disorders","volume":"14","author":"Pasche","year":"2012","journal-title":"Curr Psychiatry Rep"},{"key":"10.1016\/j.disamonth.2025.101853_bib0472","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.jad.2023.10.066","article-title":"Associations of adolescent substance use and depressive symptoms with adult major depressive disorder in the United States: NSDUH 2016-2019","volume":"344","author":"Xu","year":"2024","journal-title":"J Affect Disord"},{"key":"10.1016\/j.disamonth.2025.101853_bib0473","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.jad.2023.12.016","article-title":"Comorbid substance use disorder, major depression, and associated disability in a nationally representative sample","volume":"348","author":"Onaemo","year":"2024","journal-title":"J Affect Disord"},{"issue":"Pt A","key":"10.1016\/j.disamonth.2025.101853_bib0474","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.yebeh.2016.01.031","article-title":"Hospital care for mental health and substance abuse in children with epilepsy","volume":"57","author":"Thibault","year":"2016","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.disamonth.2025.101853_bib0475","series-title":"Clinical Aspects of Psychopharmacology in Childhood and Adolescence","first-page":"450","author":"Greydanus","year":"2012"},{"issue":"3","key":"10.1016\/j.disamonth.2025.101853_bib0476","first-page":"8","article-title":"The black book of psychotropic dosing and monitoring","volume":"54","author":"DeBattista","year":"2024","journal-title":"Psychopharmacol Bull"},{"issue":"10","key":"10.1016\/j.disamonth.2025.101853_bib0477","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002396","article-title":"van den Brink W. Gabapentin, opioids, and the risk of opioid-related death: a population-based nested case-control study","volume":"14","author":"Gomes","year":"2017","journal-title":"PLoS Med"},{"issue":"2","key":"10.1016\/j.disamonth.2025.101853_bib0478","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1001\/jamainternmed.2022.5268","article-title":"Trends in the concurrent prescription of opioids and gabapentin in the US, 2006 to 2018","volume":"183","author":"Peet","year":"2023","journal-title":"JAMA Intern Med"},{"issue":"2","key":"10.1016\/j.disamonth.2025.101853_bib0479","doi-asserted-by":"crossref","first-page":"542","DOI":"10.21037\/apm.2019.12.09","article-title":"Combining opioids and benzodiazepines: effects on mortality and severe adverse respiratory events","volume":"9","author":"Boon","year":"2020","journal-title":"Ann Palliat Med"},{"issue":"1","key":"10.1016\/j.disamonth.2025.101853_bib0480","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1186\/s12954-024-01079-7","article-title":"ADHD: prevalence and effect on opioid use disorder treatment outcome in a French sample of patients receiving medication for opioid use disorder-the influence of impulsivity as a mediating factor","volume":"21","author":"Beslot","year":"2024","journal-title":"Harm Reduct J"},{"issue":"1","key":"10.1016\/j.disamonth.2025.101853_bib0481","doi-asserted-by":"crossref","DOI":"10.1136\/bmjment-2023-300728","article-title":"Prescription amphetamines in people with opioid use disorder and co-occurring psychostimulant use disorder initiating buprenorphine: an analysis of treatment retention and overdose risk","volume":"26","author":"Tardelli","year":"2023","journal-title":"BMJ Ment Health"},{"issue":"8","key":"10.1016\/j.disamonth.2025.101853_bib0482","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1177\/10600280221141065","article-title":"Gaps in evidence-based treatment of concurrent attention deficit hyperactivity disorder and opioid use disorder: a scoping review","volume":"57","author":"Ramey","year":"2023","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.disamonth.2025.101853_bib0483","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2023.1274719","article-title":"Opioid use disorder: current trends and potential treatments","volume":"11","author":"Lee","year":"2024","journal-title":"Front Public Health"},{"issue":"2","key":"10.1016\/j.disamonth.2025.101853_bib0484","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1213\/ANE.0000000000005309","article-title":"Potential for kappa-opioid receptor agonists to engineer nonaddictive analgesics: a narrative review","volume":"132","author":"Kaski","year":"2021","journal-title":"Anesth Analg"},{"issue":"13","key":"10.1016\/j.disamonth.2025.101853_bib0485","doi-asserted-by":"crossref","first-page":"10888","DOI":"10.3390\/ijms241310888","article-title":"Targeting opioid receptors in addiction and drug withdrawal: where are we going?","volume":"24","author":"Tabanelli","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"4","key":"10.1016\/j.disamonth.2025.101853_bib0486","doi-asserted-by":"crossref","first-page":"38672","DOI":"10.52965\/001c.38672","article-title":"Historical pathways for opioid addiction, withdrawal with traditional and alternative treatment options with ketamine, cannabinoids, and noribogaine: a narrative review","volume":"10","author":"Edinoff","year":"2022","journal-title":"Health Psychol Res"},{"issue":"2","key":"10.1016\/j.disamonth.2025.101853_bib0487","doi-asserted-by":"crossref","first-page":"e13117","DOI":"10.1111\/adb.13117","article-title":"Glucagon-like peptide-1 receptor agonist, liraglutide, reduces heroin self-administration and drug-induced reinstatement of heroin-seeking behaviour in rats","volume":"27","author":"Douton","year":"2022","journal-title":"Addict Biol"},{"issue":"9","key":"10.1016\/j.disamonth.2025.101853_bib0488","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.35247","article-title":"Semaglutide and opioid overdose risk in patients with type 2 diabetes and opioid use disorder","volume":"7","author":"Wang","year":"2024","journal-title":"JAMA Netw Open"},{"issue":"1","key":"10.1016\/j.disamonth.2025.101853_bib0489","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s13722-024-00481-7","article-title":"Ecological momentary assessment and cue-elicited drug craving as primary endpoints: study protocol for a randomized, double-blind, placebo-controlled clinical trial testing the efficacy of a GLP-1 receptor agonist in opioid use disorder","volume":"19","author":"Freet","year":"2024","journal-title":"Addict Sci Clin Pract"},{"issue":"10241","key":"10.1016\/j.disamonth.2025.101853_bib0490","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1016\/S0140-6736(20)30852-7","article-title":"New directions in the treatment of opioid withdrawal","volume":"395","author":"Srivastava","year":"2020","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.disamonth.2025.101853_bib0491","first-page":"5","article-title":"Are we getting high cause the thrill is gone?","volume":"7","author":"Murphy","year":"2023","journal-title":"J Addict Psychiatry"},{"issue":"5","key":"10.1016\/j.disamonth.2025.101853_bib0492","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1176\/appi.ajp.20230828","article-title":"Vaccines as immunotherapies for substance use disorders","volume":"181","author":"Kosten","year":"2024","journal-title":"Am J Psychiatry"},{"issue":"14","key":"10.1016\/j.disamonth.2025.101853_bib0493","doi-asserted-by":"crossref","first-page":"7781","DOI":"10.3390\/ijms25147781","article-title":"Opioid-based haptens: development of immunotherapy","volume":"25","author":"Hosztafi","year":"2024","journal-title":"Int J Mol Sci"},{"issue":"4","key":"10.1016\/j.disamonth.2025.101853_bib0494","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1097\/YCO.0000000000000945","article-title":"Opioid vaccine clinical testing: lessons learned","volume":"37","author":"Luba","year":"2024","journal-title":"Curr Opin Psychiatry"},{"issue":"24","key":"10.1016\/j.disamonth.2025.101853_bib0495","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2024.06.049","article-title":"Need for strategic communications and stakeholder engagement to advance acceptability of an overdose preventing vaccine targeting fentanyl","volume":"42","author":"Weitzman","year":"2024","journal-title":"Vaccine"},{"issue":"Suppl: SIV1","key":"10.1016\/j.disamonth.2025.101853_bib0496","article-title":"The mystery of addiction","volume":"354","author":"Musto","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.disamonth.2025.101853_bib0497","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1146\/annurev-clinpsy-021815-093546","article-title":"History of the concept of addiction","volume":"12","author":"Nathan","year":"2016","journal-title":"Annu Rev Clin Psychol"},{"issue":"3","key":"10.1016\/j.disamonth.2025.101853_bib0498","first-page":"226","article-title":"Z dziej\u00f3w opium [On the history of opium]","volume":"63","author":"K\u0142ys","year":"2013","journal-title":"Arch Med Sadowej Kryminol"},{"issue":"10","key":"10.1016\/j.disamonth.2025.101853_bib0499","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1021\/acschemneuro.8b00459","article-title":"DARK classics in chemical Neuroscience: opium, a historical perspective","volume":"9","author":"Presley","year":"2018","journal-title":"ACS Chem Neurosci"},{"issue":"9","key":"10.1016\/j.disamonth.2025.101853_bib0500","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0309938","article-title":"A state-level history of opioid overdose deaths in the United States: 1999-2021","volume":"19","author":"Kline","year":"2024","journal-title":"PLoS ONE"},{"issue":"Pt 2","key":"10.1016\/j.disamonth.2025.101853_bib0501","article-title":"The fourth wave of the US opioid epidemic and its implications for the rural US: a federal perspective","author":"Jenkins","year":"2021","journal-title":"Prev Med"},{"issue":"5","key":"10.1016\/j.disamonth.2025.101853_bib0502","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1037\/a0013636","article-title":"Addressing the intersecting problems of opioid misuse and chronic pain treatment","volume":"16","author":"Denisco","year":"2008","journal-title":"Exp Clin Psychopharmacol"},{"key":"10.1016\/j.disamonth.2025.101853_bib0503","article-title":"Access challenges to opioid use disorder treatment among individuals experiencing homelessness: voices from the streets","volume":"157","author":"Hsu","year":"2024","journal-title":"J Subst Use Addict Treat"},{"issue":"1","key":"10.1016\/j.disamonth.2025.101853_bib0504","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s12954-024-00964-5","article-title":"They make it too hard and too many hoops to jump\": system and organizational barriers to drug treatment during epidemic rates of opioid overdose","volume":"21","author":"Dickson-Gomez","year":"2024","journal-title":"Harm Reduct J"},{"key":"10.1016\/j.disamonth.2025.101853_bib0505","doi-asserted-by":"crossref","DOI":"10.1016\/j.ypmed.2023.107777","article-title":"The United States opioid crisis: big pharma alone is not to blame","volume":"177","author":"Compton","year":"2023","journal-title":"Prev Med"},{"issue":"1","key":"10.1016\/j.disamonth.2025.101853_bib0506","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s40122-021-00243-2","article-title":"COVID-19 and the opioid epidemic: two public health emergencies that intersect with chronic pain","volume":"10","author":"Manchikanti","year":"2021","journal-title":"Pain Ther"},{"issue":"S1","key":"10.1016\/j.disamonth.2025.101853_bib0507","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.1089\/pop.2020.0230","article-title":"The opioid epidemic within the COVID-19 pandemic: drug testing in 2020","volume":"24","author":"Niles","year":"2021","journal-title":"Popul Health Manag"},{"key":"10.1016\/j.disamonth.2025.101853_bib0508","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1146\/annurev-publhealth-090419-102727","article-title":"A critical review of the social and behavioral contributions to the overdose epidemic","volume":"42","author":"Cerd\u00e1","year":"2021","journal-title":"Annu Rev Public Health"},{"issue":"6","key":"10.1016\/j.disamonth.2025.101853_bib0509","doi-asserted-by":"crossref","first-page":"202","DOI":"10.15585\/mmwr.mm7006a4","article-title":"Trends and geographic patterns in drug and synthetic opioid overdose deaths - United States, 2013-2019","volume":"70","author":"Mattson","year":"2021","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"7","key":"10.1016\/j.disamonth.2025.101853_bib0510","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.3390\/molecules29071544","article-title":"Analgesic peptides: from natural diversity to rational design","volume":"29","author":"Gach-Janczak","year":"2024","journal-title":"Molecules"},{"issue":"2 Suppl","key":"10.1016\/j.disamonth.2025.101853_bib0511","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/S0376-8716(03)00055-3","article-title":"From morphine clinics to buprenorphine: regulating opioid agonist treatment of addiction in the United States","volume":"70","author":"Jaffe","year":"2003","journal-title":"Drug Alcohol Depend"},{"issue":"10","key":"10.1016\/j.disamonth.2025.101853_bib0512","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1111\/eip.13446","article-title":"Informing youth-centred opioid agonist treatment: findings from a retrospective chart review of youths' characteristics and patterns of opioid agonist treatment engagement in a novel integrated youth services program","volume":"17","author":"McInerney","year":"2023","journal-title":"Early Interv Psychiatry"},{"key":"10.1016\/j.disamonth.2025.101853_bib0513","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2024.111136","article-title":"Analysis of rising cases of adolescent opioid use presentations to the emergency department and their management","volume":"258","author":"Sidlak","year":"2024","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.disamonth.2025.101853_bib0514","article-title":"Cost-effectiveness of full and partial opioid agonists for opioid use disorder in outpatient settings: united States healthcare sector perspective","volume":"160","author":"Choi","year":"2024","journal-title":"J Subst Use Addict Treat"},{"issue":"2","key":"10.1016\/j.disamonth.2025.101853_bib0515","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2024-066226","article-title":"Initiation of buprenorphine treatment of opioid use disorder in pediatric emergency departments","volume":"154","author":"Kumar","year":"2024","journal-title":"Pediatrics"},{"key":"10.1016\/j.disamonth.2025.101853_bib0516","doi-asserted-by":"crossref","DOI":"10.1016\/j.jemermed.2024.05.016","article-title":"Factors associated with take home naloxone refusal among emergency department patients participating in an opioid overdose prevention program","author":"O'Brien-Lambert","year":"2024","journal-title":"J Emerg Med"},{"issue":"7","key":"10.1016\/j.disamonth.2025.101853_bib0517","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.23954","article-title":"Opioid overdose after medication for opioid use disorder initiation following hospitalization or ED visit","volume":"7","author":"Weiner","year":"2024","journal-title":"JAMA Netw Open"},{"issue":"2","key":"10.1016\/j.disamonth.2025.101853_bib0518","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.sapharm.2023.10.014","article-title":"Sources of nonmedically used prescription psychotherapeutic drugs using real-world data from adolescents and adults assessed for substance use treatment\u20132014-2022","volume":"20","author":"Jiang","year":"2024","journal-title":"Res Social Adm Pharm"},{"issue":"5","key":"10.1016\/j.disamonth.2025.101853_bib0519","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1017\/S0033291721003652","article-title":"Validity of the DSM-5 craving criterion for alcohol, tobacco, cannabis, cocaine, heroin, and non-prescription use of prescription painkillers (opioids)","volume":"53","author":"Shmulewitz","year":"2023","journal-title":"Psychol Med"},{"issue":"3","key":"10.1016\/j.disamonth.2025.101853_bib0520","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1037\/pha0000114","article-title":"Impaired psychomotor function and plasma methadone and levo-alpha-acetylmethadol (LAAM) concentrations in opioid-substitution patients","volume":"25","author":"Newcombe","year":"2017","journal-title":"Exp Clin Psychopharmacol"},{"key":"10.1016\/j.disamonth.2025.101853_bib0521","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s13643-015-0042-2","article-title":"The impact of chronic pain on opioid addiction treatment: a systematic review protocol","volume":"4","author":"Dennis","year":"2015","journal-title":"Syst Rev"},{"key":"10.1016\/j.disamonth.2025.101853_bib0522","doi-asserted-by":"crossref","DOI":"10.1111\/1475-6773.14394","article-title":"Medicaid managed care restrictions on medications for the treatment of opioid use disorder","author":"Stewart","year":"2024","journal-title":"Health Serv Res"},{"issue":"2","key":"10.1016\/j.disamonth.2025.101853_bib0523","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.cpr.2009.10.006","article-title":"A review of opioid dependence treatment: pharmacological and psychosocial interventions to treat opioid addiction","author":"Veilleux","year":"2010","journal-title":"Clin Psychol Rev"},{"key":"10.1016\/j.disamonth.2025.101853_bib0524","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2024.1347678","article-title":"Systematic review on intentional non-medical fentanyl use among people who use drugs","volume":"15","author":"Tsang","year":"2024","journal-title":"Front Psychiatry"},{"issue":"10","key":"10.1016\/j.disamonth.2025.101853_bib0525","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.jpain.2005.05.004","article-title":"Trends in abuse of Oxycontin and other opioid analgesics in the United States: 2002-2004","author":"Cicero","year":"2005","journal-title":"J Pain"},{"issue":"1","key":"10.1016\/j.disamonth.2025.101853_bib0526","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1086\/711723","article-title":"The evolving consequences of oxycontin reformulation on drug overdoses","volume":"7","author":"Powell","year":"2021","journal-title":"Am J Health Econ"},{"issue":"5","key":"10.1016\/j.disamonth.2025.101853_bib0527","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1007\/s10571-020-01013-y","article-title":"Oxycodone in the opioid epidemic: high 'liking', 'wanting', and abuse liability","volume":"41","author":"Kibaly","year":"2021","journal-title":"Cell Mol Neurobiol"},{"key":"10.1016\/j.disamonth.2025.101853_bib0528","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2024.111084","article-title":"Predicting first use of heroin from prescription opioid use subtypes: insights from the Monitoring the Future longitudinal panel","volume":"255","author":"Dash","year":"2024","journal-title":"Drug Alcohol Depend"},{"issue":"3","key":"10.1016\/j.disamonth.2025.101853_bib0529","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1097\/ADM.0000000000000741","article-title":"Pills to powder: a 17-year transition from prescription opioids to heroin among US adolescents followed into adulthood","volume":"15","author":"McCabe","year":"2021","journal-title":"J Addict Med"},{"issue":"5","key":"10.1016\/j.disamonth.2025.101853_bib0530","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1007\/s11121-021-01226-7","article-title":"People don't just start shooting heroin on their 18th birthday\": a qualitative study of community stakeholders' perspectives on adolescent opioid use and opportunities for intervention in Baltimore, Maryland","volume":"22","author":"Linton","year":"2021","journal-title":"Prev Sci"},{"issue":"10","key":"10.1016\/j.disamonth.2025.101853_bib0531","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0258526","article-title":"Urban scaling of opioid analgesic sales in the United States","volume":"16","author":"Mullachery","year":"2021","journal-title":"PLoS ONE"},{"issue":"6","key":"10.1016\/j.disamonth.2025.101853_bib0532","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1080\/15374416.2021.1875324","article-title":"Early childhood behavioral and academic antecedents of lifetime opioid misuse among urban youth","volume":"51","author":"Rabinowitz","year":"2022","journal-title":"J Clin Child Adolesc Psychol"},{"key":"10.1016\/j.disamonth.2025.101853_bib0533","doi-asserted-by":"crossref","DOI":"10.3389\/fsoc.2021.620395","article-title":"Adverse childhood experiences predict early initiation of opioid use behaviors","volume":"6","author":"Guarino","year":"2021","journal-title":"Front Sociol"},{"issue":"6","key":"10.1016\/j.disamonth.2025.101853_bib0534","article-title":"Maintenance treatments for opiate -dependent adolescents","volume":"2014","author":"Minozzi","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"issue":"5","key":"10.1016\/j.disamonth.2025.101853_bib0535","article-title":"Opioid agonist treatment for pharmaceutical opioid dependent people","author":"Nielsen","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"issue":"9","key":"10.1016\/j.disamonth.2025.101853_bib0536","article-title":"Opioid agonist treatment for people who are dependent on pharmaceutical opioids","volume":"9","author":"Nielsen","year":"2022","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.disamonth.2025.101853_bib0537","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2020.108434","article-title":"Forty-eight years of research on psychosocial interventions in the treatment of opioid use disorder: a scoping review","volume":"218","author":"Wild","year":"2021","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.disamonth.2025.101853_bib0538","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2024-068752","article-title":"Opioid prescribing for acute pain management in children and adolescents in outpatient settings: clinical Practice Guideline","author":"Hadland","year":"2024","journal-title":"Pediatrics"},{"issue":"15","key":"10.1016\/j.disamonth.2025.101853_bib0539","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1001\/jama.2016.1464","article-title":"CDC guideline for prescribing opioids for chronic pain\u2013United States, 2016","volume":"315","author":"Dowell","year":"2016","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.disamonth.2025.101853_bib0540","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr7103a1","article-title":"CDC clinical practice guideline for prescribing opioids for pain - United States, 2022","volume":"71","author":"Dowell","year":"2022","journal-title":"MMWR Recomm Rep"},{"issue":"7S","key":"10.1016\/j.disamonth.2025.101853_bib0541","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.36076\/ppj.2023.26.S7","article-title":"Comprehensive, evidence-based, consensus guidelines for prescription of opioids for chronic non-cancer pain from the American Society of Interventional Pain Physicians (ASIPP)","volume":"26","author":"Manchikanti","year":"2023","journal-title":"Pain Physician"},{"issue":"2","key":"10.1016\/j.disamonth.2025.101853_bib0542","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1097\/JAN.0000000000000573","article-title":"Impact of the COVID-19 pandemic on functions of nursing professionals in the care of opioid use sisorder: systematic review","volume":"35","author":"Brown","year":"2024","journal-title":"J Addict Nurs"},{"issue":"10","key":"10.1016\/j.disamonth.2025.101853_bib0543","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.3109\/10826088509047242","article-title":"Narcotics anonymous: its history, structure, and approach","volume":"20","author":"Peyrot","year":"1985","journal-title":"Int J Addict"},{"key":"10.1016\/j.disamonth.2025.101853_bib0544","first-page":"26","article-title":"A review of Alcoholics Anonymous\/Narcotics Anonymous programs for teens","volume":"33","author":"Sussman","year":"2010"},{"issue":"4","key":"10.1016\/j.disamonth.2025.101853_bib0545","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1080\/02791072.2021.1979700","article-title":"The role of acceptance and change in recovery from substance use disorders","volume":"54","author":"Chen","year":"2022","journal-title":"J Psychoactive Drugs"},{"issue":"3","key":"10.1016\/j.disamonth.2025.101853_bib0546","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1080\/00952990.2024.2309648","article-title":"Internet-based, continuously available narcotics anonymous meetings: a new resource for access to Twelve Step support for abstinence","volume":"50","author":"Galanter","year":"2024","journal-title":"Am J Drug Alcohol Abuse"},{"issue":"6","key":"10.1016\/j.disamonth.2025.101853_bib0547","first-page":"459","article-title":"GPs and methadone. Primum non nocere","volume":"27","author":"MacQueen","year":"1998","journal-title":"Aust Fam Physician"},{"issue":"1","key":"10.1016\/j.disamonth.2025.101853_bib0548","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1097\/PHM.0b013e31815e87b1","article-title":"Chronic pain: second, do no harm","volume":"87","author":"Barbuto","year":"2008","journal-title":"Am J Phys Med Rehabil"},{"issue":"5","key":"10.1016\/j.disamonth.2025.101853_bib0549","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1111\/pme.12120_2","article-title":"Primum non nocere","volume":"14","author":"Franklin","year":"2013","journal-title":"Pain Med"},{"issue":"5","key":"10.1016\/j.disamonth.2025.101853_bib0550","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1001\/jamapediatrics.2016.0504","article-title":"The potential impact on children of the CDC guideline for prescribing opioids for chronic pain: above all, do no harm","volume":"170","author":"Schechter","year":"2016","journal-title":"JAMA Pediatr"},{"issue":"16","key":"10.1016\/j.disamonth.2025.101853_bib0551","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1001\/jama.2017.14567","article-title":"Ten steps the Federal Government should take now to reverse the opioid addiction epidemic","volume":"318","author":"Kolodny","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.disamonth.2025.101853_bib0552","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainres.2020.147083","article-title":"Thienorphine induces antinociception without dependence through activation of \u03ba- and \u03b4-, and partial activation of \u03bc- opioid receptor","volume":"1748","author":"Zhou","year":"2020","journal-title":"Brain Res"},{"issue":"5\u20136","key":"10.1016\/j.disamonth.2025.101853_bib0553","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1080\/17581869.2024.2385285","article-title":"Emerging innovation in pain medicines","volume":"14","author":"Gupta","year":"2024","journal-title":"Pain Manag"},{"issue":"1","key":"10.1016\/j.disamonth.2025.101853_bib0554","first-page":"1","article-title":"Taxonomic revision of the king cobra Ophiophagus hannah (Cantor, 1836) species complex (Reptilia: serpentes: elapidae), with the description of two new species","volume":"961","author":"Das","year":"2024","journal-title":"EJT [Internet]"},{"key":"10.1016\/j.disamonth.2025.101853_bib0555","series-title":"StatPearls [Internet]","article-title":"Fentanyl","author":"Ramos-Matos","year":"2023"},{"key":"10.1016\/j.disamonth.2025.101853_bib0556","series-title":"NCHS Data Brief, no 491","article-title":"Drug overdose deaths in the United States, 2002\u20132022","author":"Spencer","year":"2024"},{"key":"10.1016\/j.disamonth.2025.101853_bib0557","doi-asserted-by":"crossref","unstructured":"Amin-Esmaeili M., Farokhnia M., Susukida R., Leggio L., Johnson R.M., Crum R.M., et al. Reduced drug use as an alternative valid outcome in individuals with stimulant use disorders: findings from 13 multisite randomized clinical trials. Addiction. 2024 May;119(5):833\u2013843. doi: 10.1111\/add.16409. Epub 2024 Jan 10. Erratum in: Addiction. 2024 Oct;119(10):1849-1852. 10.1111\/add.16590.","DOI":"10.1111\/add.16409"},{"key":"10.1016\/j.disamonth.2025.101853_bib0558","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2024.104598","article-title":"Looking beyond drugs: a scoping review of recovery in the context of illicit substance use among adolescents and young adults","volume":"133","author":"Eekhoudt","year":"2024","journal-title":"Int J Drug Policy"},{"key":"10.1016\/j.disamonth.2025.101853_bib0559","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbr.2024.115221","article-title":"Opioid-environment interaction: contrasting effects of morphine administered in a novel versus familiar environment on acute and repeated morphine induced behavioral effects and on acute morphine ERK activation in reward associated brain areas","volume":"476","author":"Coelho","year":"2025","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.disamonth.2025.101853_bib0560","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2024.122758","article-title":"The immunological and pharmacokinetic evaluation of Lipid-PLGA hybrid nanoparticle-based oxycodone vaccines","volume":"313","author":"Walter","year":"2025","journal-title":"Biomaterials"},{"key":"10.1016\/j.disamonth.2025.101853_bib0561","doi-asserted-by":"crossref","unstructured":"Zang X, Skinner A, Krieger MS, Behrends CN, Park JN, Green TC, et al. Evaluation of strategies to enhance community-based naloxone distribution supported by an opioid settlement. JAMA Netw Open. 2024 May 1;7(5):e2413861. doi:10.1001\/jamanetworkopen.2024.13861.","DOI":"10.1001\/jamanetworkopen.2024.13861"},{"key":"10.1016\/j.disamonth.2025.101853_bib0562","doi-asserted-by":"crossref","first-page":"e60277","DOI":"10.2196\/60277","article-title":"Peer intervention to link overdose survivors to treatment (PILOT): protocol for a multisite, randomized controlled trial conducted within the National Institute on Drug Abuse Clinical Trials Network","volume":"13","author":"Papa","year":"2024","journal-title":"JMIR Res Protoc"},{"key":"10.1016\/j.disamonth.2025.101853_bib0563","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbr.2024.115300","article-title":"LF-DBS of the ventral striatum shortens persistence for morphine place preference and modulates BDNF expression in the hippocampus","volume":"477","author":"Lloret-Torres","year":"2025","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.disamonth.2025.101853_bib0564","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2024.110211","article-title":"Microglia-dependent peripheral neuropathic pain in adulthood following adolescent exposure to morphine in male rats","volume":"263","author":"Alami","year":"2025","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.disamonth.2025.101853_bib0565","doi-asserted-by":"crossref","DOI":"10.1016\/j.cca.2024.119995","article-title":"Clinical implications of opioid parent-metabolite ratios","volume":"565","author":"Liao","year":"2025","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.disamonth.2025.101853_bib0566","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbr.2024.115320","article-title":"Palatable feeding effects on expression and reinstatement of morphine conditioned place preference in male and female rats","volume":"477","author":"Cam","year":"2025","journal-title":"Behav Brain Res"},{"issue":"1","key":"10.1016\/j.disamonth.2025.101853_bib0567","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1615\/CritRevTherDrugCarrierSyst.2024051171","article-title":"Nanobiocatalysis: approach and applications in drug development and sensing","volume":"42","author":"Gupta","year":"2025","journal-title":"Crit Rev Ther Drug Carrier Syst"},{"issue":"1","key":"10.1016\/j.disamonth.2025.101853_bib0568","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1177\/10600280241247363","article-title":"Transdermal opioids and the quality of life of the cancer patient: a systematic literature review","volume":"59","author":"Reis","year":"2025","journal-title":"Ann Pharmacother"},{"issue":"1","key":"10.1016\/j.disamonth.2025.101853_bib0569","doi-asserted-by":"crossref","DOI":"10.1111\/aas.14544","article-title":"Time from pain assessment to opioid treatment in the Danish emergency departments-a multicenter cohort study","volume":"69","author":"Gull","year":"2025","journal-title":"Acta Anaesthesiol Scand"},{"issue":"1","key":"10.1016\/j.disamonth.2025.101853_bib0570","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1177\/10870547241288741","article-title":"Causality between ADHD, ASD, and CVDs: a two-step, two-sample Mendelian randomization investigation","volume":"29","author":"Zheng","year":"2025","journal-title":"J Atten Disord"}],"container-title":["Disease-a-Month"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0011502925000021?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0011502925000021?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,23]],"date-time":"2025-03-23T16:53:50Z","timestamp":1742748830000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0011502925000021"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":570,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["S0011502925000021"],"URL":"https:\/\/doi.org\/10.1016\/j.disamonth.2025.101853","relation":{},"ISSN":["0011-5029"],"issn-type":[{"value":"0011-5029","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Opioid use and abuse in adolescents and young adults; dealing with science, laws and ethics: Charming the COBRAS","name":"articletitle","label":"Article Title"},{"value":"Disease-a-Month","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.disamonth.2025.101853","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"101853"}}